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Abstract
The primary focus of this thesis is to synthesize biocompatible luminescent nanocrystals for visible
and short-wave infrared (1-2 p.m, SWIR) imaging applications. Quantum dots (QDs) have been
promising fluorescent probes for biomedical imaging due to their high quantum yield (QY),
narrow photoluminescence spectra, and excellent photostability. However, challenges remain to
be solved to transfer the as-synthesized hydrophobic QD to aqueous solutions while maintaining
the high QY and a compact size. This study involves the design and synthesis of a novel ligand
that can be introduced to the established QD synthesis, producing norbornene functionalized QDs
that can be readily phase transferred into water via norbornene/tetrazine click chemistry,
meanwhile allowing flexible functionalization of the QDs by incorporating a functional group on
the hydrophilic chain. This ligand system can be applied to a variety of carboxylic-ligand-
stabilized QDs, with emission spectra spanning the visible and the SWIR region. The resulting
water-soluble QDs exhibit a high QY, a small hydrodynamic diameter (HD), and excellent
colloidal stability and pH stability. Further in vitro cell labeling experiments using azido-
functionalized QDs demonstrates their potential for cell targeting applications.
As in vivo imaging in the SWIR range has further reduced background noise from tissue scattering
compared to traditional visible and near infrared (0.7-1 tm, NIR) imaging, images of higher
contrast and better resolution can be readily obtained. The next challenge is to develop SWIR
emitters that have high quantum efficiency and minimal toxicity, which is of critical importance
in order to promote this technology for clinical applications. Our study found that the emission of
luminescent gold nanoclusters can be tuned from the visible to the SWIR region by proper
selection of ligands and post ligand modifications. The SWIR-emitting gold nanoclusters have a
good QY, a HD that is small enough that they exhibit a rapid renal clearance, and images taken in
the SWIR region show better resolution of the blood vessels than in the NIR region.
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Title: Lester Wolfe Professor of Chemistry
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Chapter 1
Introduction of Quantum Dots as Fluorescent Probes
for Biomedical Imaging Applications
1.1 Introduction of Quantum Dots
0)
1...
0)C
w
Bulk
Bulk
I I- bEj
CB
VB
Decreasing Size
Figure 1-1. Schematic illustration of the quantum confinement
Semiconductor band gap increases with decreasing size of the nanocrystal.
Quantum Dots (QDs) are spherical nanoscale semiconductors, the size of which are usually
smaller than 10 nm. Because of the quantum confinement effect, the continuous density of states
in the bulk reduces to discrete atom-like states, resulting in a different energy gap of the QD from
that of the bulk material (Figure 1-1).12 When the radius of a QD is smaller than the exciton Bohr
radius (the average distance between the electron in the conduction band and the hole it leaves in
the valence band), the energy gap is strongly dependent on the nanocrystal size.
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effect.
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For QDs of the same composition, the smaller the size is, the larger the energy gap will be. This
can be explained using the particle in the box model, where the electron and the hole can be seen
as hydrogen in the Bohr model. In this case, the energy levels of the exciton can be represented as
the ground level of the particle in a box, which is proportional to I/L2 (L is the length of the box).1-
2 Therefore, by tuning the size of QDs, the absorption and emission properties can be finely tuned.
1.2 Syntheses of QDs
1.2.1 Syntheses of Visible-emitting Core/Shell QDs
Syntheses of high-quality QDs with high monodispersity in size and shape had been challenging
for a period of time until a breakthrough in the early 1990s was achieved. This method enables
syntheses of CdE (E=S, Se, Te) semiconductor nanocrystals with high uniformity by injecting
organometallic reagents into a hot coordinating solvent. 7 For example, Figure 1-2a shows the
absorption spectra of a size series of monodispersed cadmium selenide (CdSe) QDs prepared using
the hot injection method. The first extinction peak shifts from 400 nm to 700 nm with the diameter
increasing from 1.7 nm to 15 nm. Since then, more synthetic procedures based on the hot injection
method have been developed, such as replacing the acutely toxic and unstable dimethylcadmium
precursor with cadmium oxide dissolved by octadecylphosphonic acid, or introducing the use of
non-coordinating solvents.8-9
Despite the significant improvement of 1I-VI QD syntheses, the quantum yield (QY) of these
QDs are very low due to the existence of surface trap states. For example, the as-synthesized CdSe
QDs usually have a QY of less than 10%. Over the past few decades, significant progress has been
made by researchers to synthesize QDs with a uniform size, suppressed blinking, and an increased
QY. 10-2 Overcoating QDs with a shell structure has been demonstrated as a powerful solution to
21
increase the photoluminescence QY of QDs.O,' 13-14 First, the growth of a shell can passivate the
surface trap states of the core material, where the electrons and holes recombine through non-
radiative pathways. In addition, the shell material can provide isolation for the electrons or holes
from the moisture and oxygen in the surrounding environment by confining both the electron and
hole to the core material (Type I) (Figure 1-2b), or one of the electron or hole to the core material
while allowing the other to delocalize into the shell (Type II).
Radical distance
a b 0
Shell
Core CdSe i
1 OA h e 0 N
OA
' 72A -V
55A c N2C,)
-0 45 A
33 A
29 A
20A
17 A
400 500 600 700
Wavelength (nm)
Figure 1-2. (a) Absorption spectra of a CdSe size series. Figure reproduced from
C. B. Murray, Ph.D. Thesis, MIT, 1995. (b) Band structure of Type I QDs, in which
both the electron and the hole are confined to the core. (c) Synthetic setup for
CdSe/CdS core/shell QDs. A syringe pump is employed for continuous infusion of
precursors.
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In our recently described result, successful synthesis of compact high-quality quasi-Type II
CdSe/CdS core/shell nanocrystals with narrow emission linewidths and suppressed blinking has
been reported.4 The CdSe/CdS QDs were synthesized via an optimized process that maintains a
slow growth rate of the shell by using octanethiol and cadmium (II) oleate as precursors. As shown
in Figure 1-2c, the precursors were continuously injected into the reaction solution using a syringe
pump over two hours. The slow continuous precursor infusion and the relatively low reactivity of
octanethiol lead to a well-maintained size distribution during the shell growth. Since the lattice
mismatch between the CdSe core and the CdS shell is very small (3.9%), the final CdSe/CdS
core/shell QDs maintain the original crystal structure of CdSe core. The resulting CdSe/CdS QDs
have close to unity QYs, narrow and symmetric PL spectra with full-width at half-maximum
(FWHM) as narrow as 20 nm, and significantly suppressed blinking (Figure 1-3).
Because of the quasi-Type II band structure of CdSe/CdS core/shell QDs, the electron can be
delocalized in the conduction bands of both the core and the shell materials." Thus, as the shell
grows, the emission spectrum of the core/shell QDs red shifts. Therefore, it is challenging to
synthesize CdSe/CdS core/shell QDs that exhibit green emission. In order to synthesize high-
quality QDs with emission spectrum spanning the visible region, we adapted this continuous slow
precursor infusion and slow shell growth procedure to synthesize QDs of other 1I-VI materials,
such as CdSe/ZnS, and successfully prepared green- and yellow- emitting CdSe/ZnS QDs with >
90% QY and < 25 nm FWHM. We chose CdS/ZnS core/shell system to produce blue-emitting
QDs. As shown in Figure 1-3d, QDs of different compositions are synthesized, and the emission
spectra of these QDs are tunable within the visible region (400-700 nm). Moreover, the FWHM of
the emission spectra are very narrow, allowing more colors of QDs to be fitted in the visible region
with minimal spectral overlap, which can be very useful for multiplexing imaging applications.
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Figure 1-3. (a) Absorption (blue) and photoluminescence (red) spectra of CdSe/CdS
core/shell QDs. (b) Representative photoluminescence blinking trace of a single
CdSe/CdS core/shell QD. Histogram indicates the distribution of intensities observed
in the trace (Figure is adapted from ref.4 ). (c) Representative transmission electron
microscopy image of CdSe/CdS QDs. (d) Photoluminescence spectra of a color series
of QDs (blue: CdS/ZnS; cyan: CdZnSeS; green, yellow, and orange: CdSe/ZnS; red
and wine: CdSe/CdS).
1.2.2 Syntheses of Short-wave Infrared-emitting QDs
Successful synthesis of high-quality indium arsenide (InAs) -based QDs that emit in the short-
wave infrared (SWIR) region has also been reported recently.5' 16 III-V QDs have historically
struggled to match the high-quality optical properties of II-VI QDs.17-1 9 By investigating the
kinetics that govern InAs nanocrystal growth, Franke et al. managed to synthesize large InAs QDs
with narrow emission linewidths. 5 Further passivation of the InAs QDs with CdSe, CdS or ZnS
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double shells improves the QY by more than six-fold, and the photostability is significantly
enhanced. The emission spectra of these InAs/CdSe/CdS or InAs/CdSe/ZnS core/shell/shell QDs
span the entire sensitivity range of modem InGaAs SWIR cameras with QYs ranging from 16 to
82% (Figure 1-4), which are very helpful for new biomedical imaging applications in the SWIR
range. The probes can also improve infrared nanocrystal-LEDs and photon-upconversion
technology.
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Figure 1-4. (a) InAs/CdSe/CdS and InAs/CdSe/ZnS core/shell/shell QDs spanning the
entire sensitivity range of modem InGaAs cameras for wavelength-selective SWIR
imaging. (b) Representative TEM image of InAs/CdSe/CdS core/shell/shell QDs with a size
distribution of 8%. Scale bar, 20 nm (Figures are reproduced from ref.5).
As high-quality QDs emitting from the visible to the SWIR range are becoming more available
with improved synthetic methods, these core/shell QDs have found numerous applications in
biological imaging, 2 0-2 2 photovoltaic devices, 23 -25 light emitting diodes, 26 -2 8 photodetector
devices, 2 9 -3 0 and QDs displays.3 132 QD displays, especially, have gained increasing popularity on
the television market as television giants such as Samsung and TCL are pursuing wider color
gamut and improved visual experience. In this work, we will focus on the biological applications
of the improved visible- and SWIR- emitting QDs.
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1.3 QDs for Biomedical Imaging Applications
1.3.1 QD Probes for Live Cell Tracking
QDs have long been explored as alternative fluorophores to organic dyes for in vitro imaging
applications. 33-34 Due to their excellent photostability, QDs are the preferred fluorescent probes for
long-term imaging applications that require constant, high flux density excitation, such as live cell
tracking.35 -36 In fact, QDs have been demonstrated to have orders of magnitude higher
photostability than organic dyes, or even higher in the case of SWIR-emitting QDs.37 Wu et al.
monitored the fluorescence intensity changes of QDs and the organic dye Alexa Fluor 488
simultaneously in the same cell under the same excitation condition for 3 min. QDs showed higher
stability against photobleaching than Alexa 488 regardless of which part of the cell was stained
with QDs (Figure 1-5).6
Figure 1-5. Nuclear antigens were labeled with QD 630-streptavidin (red, top row),
and Alexa 488 conjugated to anti-human IgG(green, bottom row), respectively, while
microtubules were labeled with Alexa 488 conjugated to anti-mouse IgG (green, top
row), and QD 630-streptavidin (red, bottom row) simultaneously in a 3T3 cell. The
cells were continuously illuminated for 3 min using a 100 W mercury lamp.
Continuous exposure times in seconds are indicated. Scale bar, 10 pm (Figures are
reprinted from ref.6 with permission from Nature Publishing Group).
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The better photostability of QDs makes them promising candidates for live cell imaging, where
the time scale of observation for conventional organic dyes is limited due to photobleaching. For
example, Derfus et al. demonstrated live cell labeling and organelle tracking using CdSe/ZnS
core/shell QDs; 38 Jaiswal et al. reported long-term imaging of QD-labeled live cells for 14 h, and
no decline in the emission intensity of QDs was observed; 33 and Cui et al. reported using QD-
labeled nerve growth factor (NGF) to track the movement of NGF in real time in a
compartmentalized culture of rat dorsal root ganglion neurons. 39 These results indicate the
suitability of QDs as fluorescent probes for long-term, high flux density excitation imaging.
1.3.2 QD Probes for Multiplexing Imaging
A major obstacle of visualizing biological structures in all their complexity is spectral overlap
between fluorophores. Traditional fluorescent imaging is limited by the number of available
fluorophores that have minimal spectral overlap, and only three to four targets can be examined at
the same time.4 0 Fluorescence in situ hybridization, for example, is a recently described powerful
strategy for highly multiplexed transcriptome imaging. However, multiple rounds of time
consuming dehybridization, hybridization, imaging, and washing are required due to lack of
available non-overlapping fluorophores. Researchers have reported several strategies to address
this issue, including developing new optical setups that allow better resolution to detect
overlapping fluorophores, such as spectrally resolved stochastic optical reconstruction microscopy
(SR-STORM), and developing new probes that have narrow spectra and are easy to resolve from
one another. For the latter option, QDs are ideal candidate probes to solve the "lack of probes"
issue.4 1-4 2 The broad absorption spectra of QDs allows for using a single excitation source for all
fluorophores, and the narrow emission spectra enable discrimination of an increased number of
different fluorophores that can be imaged at the same time. Quantum Dot Corp. demonstrated five-
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color staining of fixed human epithelial cells using QDs (Figure 1-6) more than ten years ago.4 3
With the improved QY, narrower FWHM of QDs, and the availability of improved SWIR-emitting
QDs, multiplexing imaging with seven or more targets at the same time can be readily realized.
a b
Figure 1-6. (a) Schematic illustration of using oligo conjugated QD probes for
fluorescence in situ hybridization. (b) Multiplexing immunolabeling of fixed human
epithelial cells with five colors of QD conjugates. Nuclear antigens (Cyan, Qdot 655
anti-human), Ki-67 protein (magenta, Qdots 605 anti-rabbit), mitochondria (orange,
Qdot 525 anti-mouse), microtubules (green Qdot 565 anti-rat), and actin filaments
(red, Qdot 705 streptavidin). Figure credit to Quantum Dot Corp, adapted from ref.4 3.
1.3.3 QD Probes for SWIR In Vivo Imaging
Non-invasive in vivo fluorescence imaging in the SWIR range has been demonstrated to improve
the tissue penetration depth and spatial resolution due to the significantly reduced tissue scattering
and autofluorescence. 44 4 5 However, most organic dyes that emit in the SWIR range are highly
hydrophobic and suffer from extremely low QY once being transferred into water, and therefore
SWIR emitters with high quantum efficiencies need to be developed. With the improved
generation of SWIR emitting QDs being available, especially InAs- based QDs that have high QY
and photostability, QDs have gained increasing attention as promising fluorescent contrast agents
for SWIR in vivo imaging applications. For example, Franke et al. demonstrated non-invasive
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through-skull fluorescence imaging of the brain vasculature of murine models; 5 Bruns et al. also
reported SWIR in vivo imaging of mice using InAs- based QDs, and detailed three-dimensional
quantitative flow maps of the mouse brain vasculature were generated (Figure 1-7).3 In Bruns'
work, the glioblastoma multiforme tumor in a mouse brain was pre-labelled by injection of SWIR
QD composite particles three days before imaging, and the particles were seen to accumulate in
the collapsed and abnormal tumor blood vessels. A second dose of particles was injected and
perfusion was imaged across the entire cranial window. A multicolor angiography image of a
glioblastoma tumor through a cranial window was generated, and visualization of the overall
structure of the vasculature in the tumor margin and healthy tissue was realized. These high-
contrast and high-resolution images demonstrate the great potential of using SWIR emitting QDs
for non-invasive in vivo biomedical imaging applications.
a b
Figure 1-7. (a) Image of the brain vasculature in a mouse. A quantum dot mixture was
injected into a living mouse's vascular system, and the image was taken using an
InGaAs camera with a 1450 nm bandpass filter applied (image reproduced from M.
Allen, Master thesis, MIT, 2016). (b) A multicolor angiography image of a
glioblastoma tumor through a cranial window (figure reproduced from ref.).
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Overall, owing to their high quantum efficiency, broad absorption and narrow emission spectra,
and excellent photostability, QDs are promising fluorescent probes for live cell imaging,
multiplexing imaging, and SWIR in vivo imaging applications. However, a prerequisite for all the
above applications is to transfer the as-synthesized hydrophobic QDs into aqueous solutions while
maintaining the optical properties and compact sizes, and rendering physiological stability.
1.4 Phase Transfer of QDs
Core
Shell
Ligand---
Figure 1-8. Structure of a core-shell nanocrystal.
High-quality QDs with uniform sizes and high QYs are usually prepared using organometallic
precursors in hot coordinating solvents, and the as-synthesized QDs are passivated with long-chain
hydrophobic ligands, such as carboxylate ligands, alkylamines, trioctylphosphine (TOP) and
trioctylphosphineoxide (TOPO) (Figure 1-8). These hydrophobic ligands determine that the as-
synthesized QDs are only dispersible in organic solvent (e.g., hexane, chloroform, or toluene). In
order to use these QDs for biomedical imaging applications, surface ligand modifications are often
performed to transfer the QDs from organic solvents to aqueous solutions. Several strategies
reported by researchers so far can be classified into three categories: encapsulating QDs into
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amphiphilic polymers, coating QDs with a silica shell, and replacing the native hydrophobic
ligands with hydrophilic molecules.
1.4.1 Amphiphilic Polymer Encapsulation
Figure 1-9. Schematic illustration of encapsulating QDs into amphiphilic polymers.
Amphiphilic polymer encapsulation method has been demonstrated to be a universal method to
transfer hydrophobic ligand-capped nanocrystals of different compositions into aqueous
solutions. 464 8 The hydrophobic chains of the amphiphilic polymer can interact with the native
hydrophobic ligands on the nanocrystal surfaces through Van der Waals forces, and the
hydrophilic chains of the polymer will extend away from the center to enable water solubility
(Figure 1-9). Since the native ligands on the nanocrystal surfaces are left intact, this method
maintains the QY very well. However, small aggregates are sometimes inevitable upon water
solubilization of QDs, leading to a significant increase in the hydrodynamic diameter. For example,
4-8 nm QDs were shown to have hydrodynamic diameters of 20-40 nm after being coated with
amphiphilic polymers. 4 6 49 This large increase in hydrodynamic diameter is more than the expected
size increase from the polymer, probably due to the dangling chain of the polymer on QD surfaces,
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which will also result in non-specific binding to serum proteins or cell membranes. The large
hydrodynamic diameter of QDs limits their use in biological applications, because these polymer
coated QDs are much larger than the receptors being labeled, which will potentially interfere with
the function of labeled proteins. In addition, the large size also prevents QDs from accessing
specific tissues such as neuronal synapses.
1.4.2 Silica Coating
HOHO OH
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/OH
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HO..,,. OH
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Figure 1-10. Schematic illustration of silica coating of QDs.
Overcoating hydrophobic nanocrystals with a silica shell also provides a universal method to
render the nanocrystals water soluble.50-5 Figure 1-10 shows the shell overcoating procedure.
Usually, this process is carried out using a reverse microemulsion method (i.e. water-in-
cyclohexane reverse microemulsion). Surfactant molecules form micelles in a hydrophobic solvent,
and the addition of tetraethyl orthosilicate followed by ammonium hydroxide solution induces
deposition of silica on QDs inside the micelles.5 2 Moreover, this method enables straightforward
surface functionalization via co-condensation between tetraethyl orthosilicate and another silane
with the desired functional groups. However, the final size of the QD/silica is usually larger than
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20 nm, and later functionalization will further increase the hydrodynamic diameter.53 In addition,
precise control of the final size of QD/silica particles is still challenging. Reaction parameters such
as the size of the micelles, the concentration of the surfactant in the reaction solution, and the
stirring speed will all influence the final size. Empty silica particles without QDs encapsulated or
one silica particle with multiple QDs inside are difficult to avoid. Thus, producing high-quality
water soluble QDs using this method is very challenging, and the resulting large hydrodynamic
diameter limits the biological applications of QD/silica.
1.4.3 Ligand Replacement
Figure 1-11. Schematic illustration of replacing the hydrophobic ligands on QD surfaces
with hydrophilic molecules.
The stringent requirement on the small hydrodynamic diameter of QDs in numerous biological
applications has drawn extensive attention to the ligand-substitution method. While substitution of
native ligands with water-soluble molecules results in minimal change in size, significant loss of
QY can result from the introduction of surface trap states.14-15 Stability issues also exist. For
example, thiolated monodentate ligands or DHLA-based bidentate ligands coated QDs would
precipitate out within weeks because of the formation of disulfide bonds.56 There are also reports
about using multidentate polymers to replace the native ligands, which produces QDs with small
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HDs, satisfactory QYs and minimal nonspecific binding.56-59 However, these multidentate ligands
are usually optimized for one single nanocrystal system, depending on the composition of the
nanocrystal and the binding group of the native ligands.
1.5 Overview
Table 1-1 compares the above mentioned strategies to transfer as-synthesized hydrophobic QDs
into aqueous solutions. In addition to the disadvantages listed, syntheses of water soluble QDs
using these methods usually can only be carried out at a small scale, either limited by the method
itself or the availability of the replacing ligands. 59-61 In order to promote QDs as fluorescent probes
for biomedical imaging applications, a universal method to synthesize water-soluble QDs with a
high QY, a compact size, good physiological stability, and at a larger scale is required. In this work,
we will explore a new ligand system to realize convenient transfer of hydrophobic QDs into
aqueous solutions, while maintaining a high QY and a compact size as well as rendering high
physiological stability and flexible functionalization.
Table 1-1. Comparison of currently available methods to transfer hydrophobic QDs into aqueous
solutions.
Universal QY Stability HD
Encapsulation Yes High Moderate Large
Silica coating Yes Moderate Moderate Large
Ligand No Moderate-High Poor (monodentate) Small
replacement Good (multidentate)
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Chapter 2
A New Ligand System for Convenient Phase Transfer
of QDs
2.1 Design of a Norbornene-bearing Ligand
As mentioned in Chapter 1, synthesizing water-soluble QDs at a large scale while maintaining
a high QY and a compact size remains challenging. Our goal in this study is to develop an efficient
system for water solubilization and flexible functionalization of carboxylate ligand-passivated
QDs. In order to obtain water-soluble QDs for biomedical imaging applications at a larger scale,
we evaluated whether incorporation of a clickable moiety at the end of native ligands and further
conjugation of a hydrophilic agent would allow phase transfer of QDs while maintaining a high
QY and a small hydrodynamic diameter.
Importantly, we placed emphasis on a ligand system that would not alter the native ligands on
the nanocrystal surface post-synthesis in order to maintain high QYs. To minimize the size of the
resulting QDs in water, we decided to link hydrophilic moieties to the native hydrophobic ligands
via covalent bonds rather than Van der Waals forces between the native hydrophobic ligands and
an amphiphilic polymer.1 Norbornene has been demonstrated to undergo highly efficient and bio-
orthogonal click reactions with tetrazine.2 - Thus, we chose this group as the clickable moiety to
link the native ligand to a tetrazine-bearing hydrophilic molecule via a covalent bond. The main
ligand species for a broad range of QDs are carboxylate based ligands,4-6 as the carboxyl group
exhibits a strong binding affinity to cadmium, zinc, lead, and other common QD metals, so the
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Scheme 2-1. Schematic illustration of water solubilization and flexible functionalization of 5-
norbomene-2-nonanoic acid capped QDs via norbomene-tetrazine click chemistry.
carboxyl group was chosen as the binding group to QD surfaces. Considering the cost and
availability of reagents, we designed the ligand 5-norbomene-2-nonanoic acid, later referred to as
NB-nonanoic acid (Scheme 2-1), as the native ligand to be introduced during QD syntheses.
As shown in Scheme 2-1, the as-synthesized QDs are capped with NB-nonanoic acid. Upon
clicking with tetrazine-bearing polyethylene glycol (PEG), the QDs are readily soluble in aqueous
solutions. Further functionalization and conjugation of QDs can be achieved through the
incorporation of functional groups (azide, maleimide, biotin, thiol, acrylate, etc.) at the other
terminus of the PEG chains, and the number and ratio of functional groups on the QD surface can
be readily controlled. In summary, by incorporating a "clickable" moiety (the norbomene group)
to a ligand that can be added during QD syntheses and bind to QD surfaces, we can realize
convenient phase transfer of hydrophobic QDs into aqueous solutions as well as versatile
functionalization by clicking with a hydrophilic molecule via norbornene/tetrazine click
chemistry.
44
2.2 Synthesis of NB-nonanoic Acid 7
+0 Hydroquinone
170C,12h. 
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Figure 11. Synthetic route to NB-nonanoic acid.
Figure 2-1 shows the synthetic route to NB-nonanoic acid. The details are provided as follows.
2.2.1 Synthesis of Compound A (ethyl 10-(norborn-2-en-5-yl)decanoate)
A pressure vessel is used in this reaction, and a blast shield is recommended. To a 65 mL
pressure vessel, dicyclopentadiene (15.73 g, 0.119 mol), ethyl undecylenate (30.30 g, 0.143 mol)
and hydroquinone (39.3 mg, 0.36 mmol) were added. After sealing the vessel with a Teflon valve,
the mixture was brought up to 170 'C in an oil bath and left stirring for 20 h. The reaction solution
was then allowed to cool down and distilled under vacuum (200 mTorr). The fraction (vapor
temperature: 120-130 'C) containing Compound A was collected and set aside for 4 h. A solid
side-product precipitated out of the solution and was removed using a fritted glass filter funnel.
The filtrate was stored at 4 'C overnight to induce a secondary precipitation, and another filtration
step yielded a colorless clear oil (7.69 g, 0.028 mol, 19% yield). The IH Nuclear Magnetic
Resonance (NMR) spectrum shows the ratio of exo and endo products as 2:8 (Figure 2-2). NMR
peaks of the major isomer (endo): 'H NMR (400MHz, CDCl 3) 6 (ppm) 6.09 (m, 1H), 5.89 (m, 1H),
4.11 (q, J=7.6 Hz, 2H), 2.73 (m, 2H), 2.27 (t, J=7.4 Hz, 2H), 1.94 (m, 1H), 1.81 (m, 1H), 1.60 (m,
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2H), 1.38-1.22 (br, 11H), 1.24 (t, J=7.1 Hz, 3H), 1.19 (d, J=8.0 Hz, 1H), 1.03 (m, 2H), 0.47 (m,
1H); 13C NMR (100MHz, CDCl 3) S (ppm) 174.0, 137.0, 132.6, 60.3, 49.7, 45.5, 42.6, 38.9, 34.9,
34.5, 32.6, 30.0, 29.6, 29.4, 29.3, 28.7, 25.1, 14.4.
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Figure 2-2. (a) 'H NMR spectrum and (b) 13C NMR spectrum of the
intermediate Compound A (ethyl 1 0-(norborn-2-en-5-yl)decanoate).
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2.2.2 Synthesis of Compound B (NB-nonanoic acid)
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b
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Figure 2-3. (a) 'H NMR spectrum of NB-nonanoic acid. The peaks marked 1, 2,
and 3 are corresponding to the protons marked on the structure of the molecule in
Figure 2-1. (b) 13C NMR spectrum of NB-nonanoic acid.
While stirring, 6.81g (0.024 mol) of Compound A was added dropwise to IM solution of NaOH
in methanol (105 mL). After 4 h, the solution was transferred into a separatory funnel and washed
three times with 150 mL of hexanes to remove any unreacted material and side-products. The pH
of the methanol phase was then adjusted to 3 using IM HCl aqueous solution, and the product was
extracted into hexanes (3x150 mL). The combined 450 mL of hexanes containing Compound B
was dried over Na2SO4, and the solvent was evaporated under reduced pressure to obtain NB-
nonanoic acid as a white solid (2.82g, 0.011 mol, 47% yield). The IH NMR spectrum shows the
ratio of exo and endo products as 2:8 (Figure 2-3). NMR peaks of the major isomer (endo): 'H
NMR (400MHz, CDCl 3) 8 (ppm) 11.53 (br, 1H), 6.10 (m, lH), 5.90 (m, lH), 2.74 (m, 2H), 2.34
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(t, J=7.4 Hz, 2H), 1.96 (m, IH), 1.82 (m, 1H), 1.63 (m, 2H), 1.39-1.23 (br, 11H), 1.20 (d, J=8.0
Hz, 1H), 1.04 (m, 2H), 0.48 (m, 1H); 13C NMR (100MHz, CDCl3) S (ppm) 180.5, 137.0, 132.6,
49.7, 45.5, 42.7, 38.9, 34.9, 34.2, 32.6, 30.0, 29.6, 29.4, 29.2, 28.8, 24.8.
We have successfully performed this synthesis at six times the scale described above and have
obtained similar reaction yields.
2.3 Thermo-stability of NB-nonanoic Acid
50 *C
A AI~AK __ __
100 c
150 OC
200 OC
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Figure 2-4. 'H NMR spectra of NB-nonanoic acid. Each spectrum corresponds to an
aliquot that was incubated up to a particular temperature (50 'C, 100 0C, 150 0C, and
200 *C) and kept at that temperature for 40 min. Signs of the retro Diels-Alder reaction
and oxidation start to become evident at temperatures above 200 "C (indicated in the red
rectangular box).
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250 "Cretro Diels-Alder reaction
oxidation
Because QD syntheses are usually conducted at a high temperature of over 200 'C, we studied
the thermo-stability of NB-nonanoic acid by heating the molecule up stepwise and tracking
structural changes using 1H NMR spectroscopy. As shown in Figure 2-4, the ligand is stable up to
200 0C, and the norbornene moiety undergoes a retro-Diels-Alder decomposition beyond that point.
Thus, for QD syntheses that are performed higher than 200 'C (CdSe/CdS QDs, CdSe/ZnS QDs,
etc.), the ligand is added as the final step when the reaction solution cools down to below 200 'C;
for syntheses that are performed lower than 200 'C (PbS QDs), NB-nonanoic acid is added in the
form of metal carboxylate.
2.4 Syntheses of NB-nonanoic Acid-capped QDs
We applied the NB-nonanoic ligand to our recently described CdSe/CdS QDs, which are
synthesized at 310 'C, by modifying the published method.8 Briefly, 100 nmol of CdSe QDs were
added to a mixture of 1-octadecene (ODE, 3 mL) and oleylamine (3 mL). The reaction solution
was degassed under vacuum at room temperature for 1 h and at 120 'C for 20 min. The solution
was then heated to 310 'C under nitrogen flow, and a desired amount of cadmium (II) oleate (1.5
mL of 0.2M Cd-oleate, diluted in 3 mL ODE) and octanethiol (1.2 equivalents with respect to Cd-
oleate, diluted in 3 mL ODE) were injected dropwise into the reaction solution at 1.5 mL/h using
a syringe pump when the temperature reached 240 'C. The QDs were annealed at 310 'C for 30
min after precursor infusion before cooling to 150 'C. 2 grams of NB-nonanoic acid dissolved in
2 mL of ODE was injected, and QDs were annealed at 150 'C for 1 h. The resulting CdSe/CdS
QDs were precipitated by adding acetone and then redispersed in hexanes twice. For ligand
addition to existing QDs, QD-norbornene were synthesized by adding NB-nonanoic acid to QDs
dispersed in toluene, and the mixture was stirred in a 70 'C oil bath for 2 h. The resulting CdSe/CdS
QDs were precipitated out by adding methanol and redispersed in chloroform.
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We performed 'H NMR to confirm that the NB-nonanoic acid ligands are bound to QD surfaces.
For a more precise analysis, we did a secondary purification using a home-built dialysis setup
(Figure 2-5) that can efficiently remove free unbound ligands prior to 1H NMR analysis. The 'H
NMR spectrum of the QDs shows broadening and loss of resolved splitting of all the resonance
peaks of NB-nonanoic acid (Figure 2-6 insets as an example) as well as loss of the a-proton Peak
3, indicating that the NB-nonanoic acid ligands are bound to the surface of QDs. 9-1
a b
C
0
0
0
Figure 2-5. (a) A home-built setup to purify QDs by allowing small molecules to diffuse out of
the porous fiber filters. This setup includes a Masterflex L/S series peristaltic pump from Cole
Palmer and a MicroKros@ hollow fiber filter from Spectrum Labs. (b,c) Schematic illustration
of the purification process. The filter consists of several porous fiber tubes inside a larger plastic
tube. The QD solution flows inside the fiber tubes, while solvent containing small molecules
diffuses out, and is collected. After evaporating the collected solvent, the mass of the residue
(small molecules that diffused out of the fiber tubes) can be weighed. Our QD solution was
purified on this system until no small molecules were detected. This setup provides a mild way
to purify QDs, and the process can be easily scaled up.
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Figure 2-6. 'H NMR spectrum of (a) NB-nonanoic acid and (b) NB-nonanoic acid
capped CdSe/CdS QDs (insets are zoomed-in areas indicated in the red box).
Syntheses of NB-nonanoic acid capped CdSe/CdS nanorods, InAs/CdSe/ZnS QDs, and PbS
QDs are provided in the experimental details.
2.5 NB-nonanoic Acid to Oleic Acid Ratio on QD Surfaces
The final ratio of NB-nonanoic acid to the competing oleic acid ligands on the QD surfaces was
also investigated. After careful analysis, we note that a very small amount of oleylamine exists in
the QD solution, as shown in Figure 2-7. The a-proton peaks of oleylamine are visible on the 'H
NMR spectrum of QD-norbornene. However, the splitting of the peaks is still well resolved, and
the coupling constant remains the same. Thus we conclude that the little amount of oleylamine in
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Figure 2-7. Zoomed-in 1H NMR spectra of oleylamine and QD-norbornene.
the QD-norbornene solution is not bound to QD surfaces. By integrating the peaks of double bond
protons (NB-nonanoic acid: 5.8-6.2 ppm, oleic acid: 5.3 ppm) on Figure 2-6b, we obtained a
quantitative NB-nonanoic acid to oleic acid ratio of 4:1. Thus, we conclude that NB-nonanoic acid
accounts for about 80% of the capping ligands on QD surfaces. We used 'H NMR spectroscopy to
study the effect of the annealing temperature on final ligand ratios between 50 'C and 200 'C
(Figure 2-8). As shown in Figure 2-9, when the annealing temperature is higher than 100 'C, the
NB-nonanoic acid to oleic acid ratio on QD surfaces remains constant as 4:1, which is similar to
the ratio of the ligands that were added to the reaction solution (4.2:1) (see Figure 2-8 description).
This finding is consistent with a Langmuir-like binding behavior, assuming a similar binding
equilibrium constant for the two carboxylate ligands. In contrast, our data indicates that annealing
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at 50 'C for one hour does not provide the needed activation energy to overcome a Cd-oleate bond.
We chose an annealing temperature of 150 'C for all following syntheses.
50 -C
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Figure 2-8. 'H NMR of QD-norbornene at different annealing temperatures. The peaks at 5.8-6.2
ppm correspond to the carbon-carbon double bond protons of the norbornene group, and the peaks
at 5.35 ppm correspond to the double bond protons of oleic acid.
*Calculation of the ratio of NB-nonanoic acid to oleate species added to the reaction solution: 0.2
M Cd-oleate was synthesized by dissolving CdO (2.5746 g, 0.02 mol) in 40 mL oleic acid,
followed by adding ODE to make the total volume 100 mL. 1.5 mL of 0.2 M Cd-oleate was used
as the cadmium precursor, which corresponds to 1.5*40/100=0.6 mL oleic acid (0.0019 mol oleate
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species, including Cd-oleate and free oleic acid). 2.0 g of NB-nonanoic acid (0.008 mol) was added
to the reaction solution. So the NB-nonanoic acid to oleate ratio in the reaction solution is 4.2:1.
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Figure 2-9. NB-nonanoic acid percentage on CdSe/CdS QD surface at
different annealing temperatures when a 4.2:1 NB-nonanoic acid to
oleate species molar ratio is added in the reaction solution.
2.6 Phase Transfer of QD-norbornene
2 ONtriethylamnine
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Figure 2-10. Synthetic routes to Tetrazine-PEG-N3 and Tetrazine-PEG-OMe.
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Figure 2-11. (a) Absorption and photoluminescence (PL) spectra of CdSe/CdS QDs before
(blue) and after (red) water solubilization. PL intensities were adjusted according to QYs. (b)
DLS measurement of water soluble CdSe/CdS QDs. (c) Linear relationship between integrated
PL and relative concentrations of water-soluble CdSe/CdS QDs; inset is a zoomed-in area
indicated by the blue rectangle. (d) Colloidal stability test of water soluble CdSe/CdS QDs at
different pH values (5-10).
After demonstrating the synthesis of NB-nonanoic acid capped "clickable" CdSe/CdS QDs (QD-
norbornene), we investigated the subsequent reaction with tetrazine-PEG to make the QDs water
soluble. Tetrazine-PEG-OMe and tetrazine-PEG-N3 were synthesized according to Figure 2-10,
followed by purification using a silica column. QD-norbornene in chloroform was added to a
mixture of tetrazine-PEG-OMe and tetrazine-PEG-N3. Upon phase transfer to aqueous solution,
we detected a negligible change in the QD absorption and PL spectra but a drop in the PL QY from
close to 100% to about 70% (Figure 2-1 la). Our approach preserves -70% of the original QY,
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which is comparable to other methods but yields a higher absolute QY value. 12-14 Dynamic light
scattering (DLS) measurements show a hydrodynamic diameter (HD) of 12 nm (Figure 2-11 b),
which is about 3 nm larger than the inorganic core (Figure 2-12), a reasonable diameter increase
caused by the NB-nonanoic acid and PEG12 chains. The resulting water soluble QDs are stable
against serial dilution with phosphate buffered saline (PBS), with the integrated emission
remaining linear over 3 decades of dilution (Figure 2-11 c). This indicates a strong binding constant
between the ligands and inorganic core,' 5 resulting in high colloidal stability that is essential for
biological applications where very dilute samples are used. We also investigated the stability of
our QD dispersions with respect to the physiological pH range. The integrated PL intensity of the
solutions decreases slightly with decreasing pH, presumably due to the protonation of NB-
nonanoic acid and loss of ligand at lower pH (Figure 2-11d). Our characterization shows that our
novel ligand system generates water soluble CdSe/CdS QDs with a small HD, a high QY, and
good colloidal stability.
Figure 2-12. Transmission electron microscopy (TEM) image of
CdSe/CdS QDs.
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2.7 A Universal Ligand
We highlight that our new ligand system not only achieves promising results for our recently
described CdSe/CdS QDs,8 but that it can also be readily applied to other carboxylate ligand-
stabilized nanocrystal systems, including CdSe/CdS nanorods, CdSe/ZnS QDs, InAs/CdSe/CdS
QDs, and PbS QDs. After clicking with hydrophilic agents, the emission spectra of those water-
soluble nanostructures cover a broad wavelength range from the visible to the infrared (Figure 2-
13), and their QYs are well maintained (Table Si). These water-soluble QDs are promising
candidate probes for multiplexed imaging applications, and InAs- and PbS-based QDs, especially,
have received recent attention as emissive materials for in vivo imaging in the short-wave
infrared. 16-17
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Figure 2-13. Emission spectra of CdSe/ZnS QDs, CdSe/CdS
InAs/CdSe/CdS QDs in aqueous solutions.
nanorods, PbS QDs, and
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InAs/CdSe/CdS PbS CdSe/CdS CdSe/ZnS
Table 2-1. QYs of several NB-nonanoic acid capped nanocrystals before and after water
solublization.
QY(%) CdSe/ZnS QDs InAs/CdSe/CdS QDs CdSe/CdS Nanorods PbS QDs
(Em: 545 nm) (Em: 1080 nm) (Em: 630 nm) (Em: 980 nm)
As synthesized >95 28 92 73
In water 57 22 50 40
2.8 Experimental Details
Materials
Dicyclopentadiene, ethyl undecylenate (97%), hydroquinone (99%), 1 -octadecene (ODE, 90%),
trioctylphosphine oxide (TOPO 99%), trioctylphosphine (TOP, 97%), oleylamine (70%), oleic
acid (90%), 1-octanethiol (> 98.5%), lead acetate trihydrate (99.99 %), hexamethyldisilathiane,
and triethylamine were obtained from Sigma Aldrich. Cadmium oxide (CdO, 99.998%), selenium
powder (99.999%) and octadecylphosphonic acid (ODPA, 97%) were purchased from Alfa Aesar.
Azido-dPEG12-NHS ester and m-dPEG12-NHS ester were purchased from Quanta BioDesign.
Amicon@Ultra diafiltration filters (50K cutoff) were purchased from EMD Millipore.
Instrumentation
1H NMR and 13 C NMR spectra were obtained on a Bruker DRX 400 NMR spectrometer.
Absorption spectra of QDs were measured on an Agilent UV-Visible spectrophotometer. PL
spectra of CdSe/CdS QDs, CdSe/CdS nanorods, and CdSe/ZnS QDs were taken on a FluoroMax3
spectrofluorometer (HORIBA), and PL spectra of PbS QDs, InAs/CdSe/ZnS were collected using
a thinned InGaAs point detector (Thorlabs, DET ION) with a 532 nm laser excitation. Transmission
electron microscopy (TEM) images of CdSe/CdS QDs were taken on a JEOL 2010 advanced high
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performance TEM. Quantum yields were measured using an integrating sphere (Labsphere RTC-
060-SF) under a diode laser excitation. A longpass filter was used to block the excitation, and
signal from the sample was collected using a calibrated detector through a lock-in amplifying
system.
Synthesis of CdSe QDs
CdSe cores were synthesized according to a literature method,' 8 except that the reaction was scaled
up with twice the amount of chemicals used. Briefly, CdO (120 mg), octadecylphosphonic acid
(ODPA, 560 mg) and trioctylphosphine oxide (TOPO, 6 g) were added to a 100 mL flask. The
mixture was heated to 150 'C and degassed under vacuum for 1 hour. Under nitrogen flow, the
reaction mixture was heated to 330 'C to form a clear solution. After adding 3.0 mL of
trioctylphosphine (TOP) to the solution, the temperature was brought up to 380 'C, at which point
a Se/TOP (120 mg of Se in 1.0 mL of TOP) solution was swiftly injected into the flask. When the
CdSe core nanocrystals reached the desired size, the reaction was terminated by removing the
heating mantle. 10 mL of hexane was added to the resulting reaction solution to form a stock
solution.
Synthesis of Cd-oleate
To a 250 mL three-neck round bottom flask, cadmium oxide (2.57 g, 0.02 mol) and oleic acid (40
mL) were added. Under stirring, the mixture was degassed under vacuum for 10 min at room
temperature, 1 h at 80 0C, and 1 h at 120 0C. The temperature was then brought up to 160 'C under
nitrogen atmosphere, and held at this temperature until the solution became clear. The reaction
solution was allowed to cool down to 120 'C, and ODE was added to make the total volume 100
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mL. The solution was degassed at 80 'C for one hour before being transferred into three 40 ml
vials. The resulting 0.2 M Cd-oleate was stored at room temperature as a slightly yellow soft solid.
Syntheses of QD-norbornene
Syntheses of NB-nonanoic acid capped CdSe/CdS nanorods and InAs/CdSe/ZnS QDs are similar
to that of CdSe/CdS QDs. NB-nonanoic acid was added after precursor infusion when the reaction
solution cooled down to below 200 'C, followed by annealing at that temperature for 1 h.
PbS QDs were synthesized based on the method of Hines et al.1 9 Briefly, 0.306 g of lead acetate
was dissolved in 8 mL of 1 -octadecene with oleic acid to have a final concentration of 0.1 M. Then
the solution was degassed at 80 'C for at least two hours. In a glovebox, 105.5 piL of
hexamethyldisilathiane was diluted in 5 mL of ODE and then quickly injected into the flask with
the lead precursor at 60 'C. In our synthesis, oleic acid was partially (25%-75% in molar ratio)
substituted by NB-nonanoic acid. The reation was quenched immediately using an ice bath. The
resulting PbS QDs were precipitated out by adding acetone to the growth solution. The supernatant
was discarded and the precipitate was rewashed with hexane and acetone. Finally, the NB-
nonanoic acid capped PbS QDs were dispersed in chloroform and stored in an inert atmosphere.
Syntheses of Tetrazine-PEG-OMe and Tetrazine-PEG-N3
5 mg of (4-(1,2,4,5-tetrazin-3-yl)phenyl) methanamine hydrochloride were dissolved in 500 pL of
dichloromethane (DCM) with dropwise addition of about 50 jiL of triethylamine. While stirring,
azido-dPEG®12-NHS ester or m-dPEG912-NHS ester solution (15 mg in 100 ptL DCM) was
added and the mixture was allowed to react at room temperature for 4 h. The resulting solution
was purified using a silica column with a solution of 7% methanol in DCM as the flushing solvent.
The eluted pink product was collected and stored at 4 'C.
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Synthesis of QD-PEG-N3
5 mg of QD-norbornene was dispersed in 100 pL of chloroform and added to a mixture of tetrazine-
PEG-OMe and tetrazine-PEG-N3 solution (4mg, dissolved in 200 pL of chloroform). The molar
ratios of these two tetrazine ligands added to the reaction were 0:1, 0.25:0.75, 0.5:0.5 and 1:0 to
make QD-N 3(100%), QD-N 3(75%), QD-N 3(50%), and QD-OMe, respectively. The reaction
solution was stirred for 2 h at room temperature, followed by dropwise addition of hexanes until
the solution became turbid. After centrifugation, the upper pink solution was discarded, and the
precipitate was redispersed in 1 x PBS. The resulting water-soluble QDs were washed five times
using a 50kDa cutoff dialysis filter to remove excess free ligands. The QDs in PBS solution were
purified using a 0.2 ptm syringe filter and stored at 4 'C for further use.
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Chapter 3
Live Cell Labeling with QD Probes
3.1 Chapter Overview
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Figure 3-1. Water-soluble QDs prepared using our newly developed
ligand system are used to target metabolically labeled cancer cells,
and high specific targeting efficiency was achieved.
As mentioned in the previous chapter, we successfully transferred the as-synthesized
hydrophobic QDs into water using our new NB-nonanoic ligand system via a norbornene/tetrazine
click reaction, and versatile functionalization of the water-soluble QDs can be readily realized by
incorporating functional groups (azide, maleimide, biotin, etc.) at the terminus of the PEG chain
(Figure 3-1). The resulting water-soluble QDs have a high QY, a compact hydrodynamic diameter
(HD) of -12 nm, and excellent colloidal stability, enabling their use as fluorescent probes for
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biological applications. In this chapter, we investigated whether these water-soluble QDs prepared
using our new ligand system are suitable for cellular imaging. More specifically, we studied the
non-specific cellular binding and active cellular targeting using our water-soluble QDs.
In this work, we demonstrated the simplicity and effectiveness of our approach by incubating
azido-functionalized CdSe/CdS QDs (QD-N3) with mouse 4T1 breast cancer cells that were
metabolically labeled with a dibenzocyclooctyne (DBCO) bearing unnatural sugar (Figure 3-1).
Both flow cytometry analysis and confocal imaging showed improved cellular uptake of QD-N3
mediated by the highly efficient DBCO/N 3 click chemistry. While for the control cells without
pre-treatment with the DBCO-bearing sugar, little QD fluorescence was observed, indicating
minimal non-specific cellular binding.
3.2 Cell Labeling Using CdSe/CdS QDs
N ,N
HO 0 2 Cancer cell _NHO NN
H 40 H N
ManDBCO DBCO-Modified Membrane Membrane-attached QD
Scheme 3-1. Schematic illustration of using the azido-functionalized QDs to label cells. The cells
are pretreated with ManDBCO, which ends up being expressed on cell membranes through cellular
metabolic glycosylation pathways.
In addition to studying endocytosis-mediated cellular uptake, we also studied the targeted uptake
of QD-N 3 into chemically labeled cells via efficient click chemistry. Metabolic labeling of cells
using unnatural sugars has proven to be an effecitve methodology to introduce artificial chemical
receptors to cell surface, as an alternative to endogenous protein receptors that have shown
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limitations for cell targeting.1-3 Here we explored targeting cancer cells with DBCO groups on the
cell surface using QD-N3 probes. Wang et al. recently reported a DBCO-bearing unnatural sugar,
Ac4ManDBCO, that metabolically labels LS 174T colon cancer cells with DBCO groups for
subsequent targeting of azido-modified nanomedicines. 4 5 To label cells with QD-N3, we adapted
this procedure by using a new unnatural sugar, ManDBCO, a water-soluble de-acetylated analog
of Ac4ManDBCO, for metabolic labeling of 4T1 breast cancer cells. We hypothesized that
ManDBCO would participate in the cellular glycosylation pathways and end up being expressed
on the cell surface in the form of glycoproteins, functioning as artificial receptors, and that these
receptors would improve cellular uptake of QD-N 3 via a catalyst-free and bio-orthogonal
DBCO/N 3 click reaction (Scheme 3-1).6-7
3.2.1 Synthesis of ManDBCO
D-Mannosamine hydrochloride (0.1 mmol) and triethylamine (0.1 mmol) were dissolved in
methanol, followed by the addition of DBCO-NHS (0.12 mmol). The reaction mixture was stirred
at room temperature for 48 h. The solvent was removed, and the crude product was purified via
preparative HPLC using acetonitrile and water as the mobile phases. 1H NMR spectrum and mass
spectrum of the final product was obtained to confirm the structure of ManDBCO (Figure 3-2).
'H NMR (500 MHz, DMSO-d6) 6 (ppm): 7.71-7.22 (m, 8H, Ph), 7.06 (t, J = 10.3 Hz, 0.5H,
NHC(O)), 6.38 (ddd, J= 14.8, 4.4, 1.5 Hz, 1H,CHOCH), 6.31 (td, J= 7.3, 1.5 Hz, 0.5H,NHC(O)),
5.04 (d, J = 14.0 Hz, 2H, C(O)NCH 2), 4.71 (td, J = 5.8, 1.5 Hz, 1H, NHCHCHCH),
4.68&4.60&4.06 (in, 1H, OH), 4.56&4.52 (dd, J = 5.4, 1.5 Hz, 1H, NHCHCHCH), 4.33-4.23 (m,
1H, NHCHCHCH), 3.88&3.68 (m, 1H, CH2CHOCH), 3.63 (in, 1H, OH), 3.60 (m, 1H, OH),
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3.51&3.46 (m, 2H, CH2CHOCH), 3.16&3.02 (m, 1H, OH), 2.57&2.34 (i, 2H,
C(O)CH2CH2C(O)N), 2.07&1.77 (m, 2H, C(O)CH2CH2C(O)N).
MS: 467.2 m/z corresponds to [M+H]*, and 955.4 m/z corresponds to [2M+Na]-.
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Figure 3-2. (a) Chemical structure and 'H NMR spectrum of ManDBCO. (b) Mass
spectrum of ManDBCO.
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3.2.2 4T1 Cell Labeling Using QD-N 3
We investigated whether 4T1 cells treated with ManDBCO express DBCO groups on the cell
membranes and can mediate the specific binding of QD-N 3 via a click reaction. 4T1 cells were
treated with ManDBCO for three days, followed by incubation with QD-N 3 (50% N3, Emission:
625 nm) for 2 h. After incubation, the cells were washed multiple times to remove free QD-N 3
prior to confocal microscopy and flow cytometry analyses. As shown in Figure 3-3a, QD-N 3 shows
significantly enhanced cellular uptake in 4T1 cells pretreated with ManDBCO compared to control
cells without ManDBCO treatment. We note that the passive cellular uptake of QDs is very low
even after 4 h of incubation (Figure 3-3b), perhaps due to the slightly net negative charge of the
QD probe (Figure 3-4).8 The covalently conjugated QD-N 3  eventually enters
endosomes/lysosomes, as evidenced by confocal images (Figure 3-3 a-b). Increasing the
incubation time from 2 h to 4 h increases the cellular uptake of QD-N 3 from 29% to 46% (Figure
3-3c), indicating a continuous click reaction-mediated cellular uptake over time. After 4 h of
incubation, negligible change of fluorescence intensity in control cells without ManDBCO
treatment was observed (Figure 3-3 d-e), further highlighting the minimal nonspecific cellular
uptake of QD-N 3. In contrast, cells pretreated with ManDBCO exhibit an obvious increase in
fluorescence intensity overall (Figure 3-3f). To exclude the impact of cell-surface DBCO on the
permeability of cells, we incubated ManDBCO-pretreated 4T1 cells with QD-OMe under the same
conditions, which shows minimal cellular internalization (Figure 3-3g). More confocal images and
representative flow cytometry profiles are available in Appendix. These experiments demonstrate
that ManDBCO can metabolically label 4T1 cells with DBCO groups, and this leads to cellular
internalization of QD-N 3 via a click reaction.
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Figure 3-3. Confocal images of 4Tl cells treated and not treated with 50 pM ManDBCO
sugar after incubation with QD-N3(50%) for (a) 2 h and (b) 4 h. (c) Percent cellular uptake
of QD-N3(50%) by 4T1 cells with (orange) or without (blue) pre-treatment of 50 pM
ManDBCO. (d-f) Representative flow cytometry profiles of 4T1 cells after incubation with
QD-N3(50%). The PE-Texas Red channel was used. Cell treatment condition and incubation
time information is provided at the top of each figure. (g) Confocal images of 4T1 cells
pretreated with 50 pM ManDBCO and incubated with QD-OMe for 2 h. (Color code for all
confocal images: blue: DAPI, green: Alexa Fluoro 488 membrane stain, red: QD, scale bar:
10 pim.)
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Figure 3-4. Gel electrophoresis images of water soluble CdSe/CdS QDs.
Upper image was taken at 30 min, and lower image was taken at 60 min under
UV light (0.8% agarose gel, 60 V electric field). The red gradient line indicates
gel well line.
3.2.3 Cell Labeling with Higher N3 Density on QD Surfaces
Given that the click reaction between N3 and cell-surface DBCO groups mediates the cellular
uptake of QD-N 3, we further studied whether a higher density of N3 on the surfaces of QDs would
provide better cell targeting efficiency. QD-N3 with different molar percentages of tetrazine-PEG-
N3 (50%, 75%, and 100%) were prepared, and all of them showed excellent water solubility. 4T1
cells were treated with ManDBCO for three days, followed by incubation with QD-N 3(50%), QD-
N3(75%), and QD-N 3(100%), respectively, for 2 h. Cells without ManDBCO treatment were used
as control. Confocal images show significantly improved cellular internalization of QD-N3(100%)
compared with QD-N 3(50%), while the control cells exhibit similar minimal QD fluorescence
(Figure 3-5). All formulations show little passive uptake by 4T1 cells (Figure 3-5d, Appendix
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Figures), further highlighting the minimal nonspecific binding of these QD-N3. More confocal
images and representative flow cytometry profiles are available in Appendix.
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Figure 3-5. Confocal images of 4T1 cells (a) treated with 50 piM ManDBCO, and (b) not
treated with ManDBCO and incubated with QD-N3(100%) for 2 h (blue: DAPI, green: Alexa
Fluoro 488 membrane stain, red: QD, scale bar: 10 ptm). (c) Percent cellular uptake of QD-
N 3(50%), QD-N 3(75%), and QD-N3(100%) after 2 h incubation with 4T1 cells that were
pretreated with 50 uM ManDBCO (orange) or PBS (blue). (d-f) Representative flow
cytometry profiles of 4T1 cells after incubation with QD-N 3. The PE-Texas Red channel was
used. Cell treatment condition and incubation time information is provided at the top of each
figure.
3.3 QD-oligo Probes
We further demonstrated that azido or maleimide functionalized QDs (QD-N3, QD-Mal) can be
conjugated with DNA oligos or antibodies for more specific targeting applications. Single-strand
DNA or RNA oligos conjugated with fluorophores are usually designed as probes for targeting
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Figure 3-6. (a) GFC trace of QD-N3 and DBCO-oligo conjugation reaction solution. (b)
PL intensities of QD (orange) and Alexa 647 (blue) of GFC fractions of QD-oligo and
Alexa647-oligo hybridization mixture.
chromosomes and RNAs by hybridizing with complimentary sequences. 9-"1 As we discussed in
Chapter 1, QD probes are promising alternative fluorophores to organic dyes for highly
multiplexed transcriptome imaging. 12 -' Thus, we conjugated a single strand 32-mer DNA oligo to
QD-N3 (Emission: 610 nm) to make a QD-oligo fluorescent probe for gene sequence targeting.
QD-N3 was reacted with DBCO-oligo and purified using gel filtration chromatography (GFC). As
shown in Figure 3-6a, the retention time of the first peak (assigned to QD-oligo) is 26 min, which
corresponds to a HD of 15 nm according to our column calibration curve (Figure 3-7), indicating
successful conjugation of oligos to QDs. We then tested the hybridization efficiency of QD-oligo
probes to a complimentary oligo sequence that is terminated with an Alexa 647 dye molecule. The
reaction mixture was analyzed using GFC, and fractions were collected and the PL intensity of
QDs and Alexa 647 of each fraction was read on a plate reader. Figure 3-6b shows a strong overlap
of the QD signal (Exitation: 450 nm, Detection: 600 nm) and Alexa 647 signal (Exitation:630 nm,
Detection: 670 nm), indicating that the Alexa 647-oligo successfully hybridized with the
complimentary QD-oligo. The smaller peak at about 33 min corresponds to free Alexa 647-oligo,
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which from the peak area was calculated to be 19% of all Alexa 647-oligo added (Figure 3-6b).
We have thus successfully demonstrated secondary functionalization of these water soluble QDs
with DNA oligos for further targeting with high efficiency.
24-
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24 32 40
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Figure 3-7. A superose 6 size-exclusion column was calibrated with protein standards containing
thyroglobulin, bovine y-globulin, chicken ovalbumin, equine myoglobin, and vitamin B12 from
Bio-Rad (black squares). The red curve is a calibration curve of hydrodynamic diameter versus
retention time based on the protein standards.
3.4 Summary
We report a new, versatile ligand system that yields "clickable" QDs of various formulations at
the hundred nmol scale. The ligand is characterized with a carboxylic acid group at one end for
binding to metal sites on QD surfaces and a norbornene group at the other for flexible
functionalization. Upon attaching a tetrazine-PEG molecule using click chemistry, we were able
to produce water soluble QDs with a high QY, a compact HD, and high colloidal stability.
Furthermore, we demonstrated the efficacy and versatility of this ligand system by using azido
functionalized CdSe/CdS QDs to label ManDBCO-treated 4T1 cancer cells, and to conjugate QDs
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with single strand DNA oligos for further targeting. Our results demonstrate that this ligand system
can generate high-quality water-soluble and clickable QDs in quantity for biological applications.
3.5 Experimental details
Materials
(4-(1,2,4,5-tetrazin-3-yl)phenyl) methanamine hydrochloride (95%), trimethylamine (>99%),
D-Mannosamine hydrochloride, dibenzocycloocyne-NHS ester (DBCO-NHS), and
dibenzocyclooctyne-PEG 4-NHS ester (95%) were obtained from Sigma Aldrich. Illustra NAP-5
columns were obtained from GE Healthcare Life Sciences. DNA oligos were ordered from IDT.
Instrumentation
'H NMR was obtained on a Bruker DRX 400 NMR spectrometer. Liquid chromatography-mass
spectrometry (LC-MS) analyses were conducted on the Agilent 1290 Infinity LC System equipped
with an Agilent 6140 Quadruple mass spectrometer, using acetonitrile and water containing 0.1%
formic acid as the mobile phases at a rate of 0.6 mL/min. Confocal images were taken using a
ZEISS LSM 710 NLO system. Cell flow cytometry analysis was carried out on a BD LSR II
system. PE Texas Red channel (610 10 nm) was chosen to detect the QD signal. The gel filtration
chromatography (GFC) setup was an AKTAprime Plus system equipped with a Superose 6 10/300
GL column. The mobile phase was Ix PBS, and measurements were carried out at a flow rate of
0.5 mL/min. 250 ptL of each sample was injected, and absorbance at 280 nm was recorded. GFC
fractions of QD-oligo hybridization mixture were read on a BioTek Synergy 4 Microplate Reader.
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Synthesis of QD-PEG-N 3
5 mg of QD-norbornene was dispersed in 100 gL of chloroform and added to a mixture of
tetrazine-PEG-OMe and tetrazine-PEG-N3 solution (4 mg, dissolved in 200 pL of chloroform).
The molar ratios of these two tetrazine ligands added to the reaction were 0:1, 0.25:0.75, 0.5:0.5
and 1:0 to make QD-N 3(100%), QD-N3(75%), QD-N 3(50%), and QD-OMe, respectively. The
reaction solution was stirred for 2 h at room temperature, followed by dropwise addition of hexanes
until the solution became turbid. After centrifugation, the upper pink solution was discarded, and
the precipitate was redispersed in 1 x PBS. The resulting water-soluble QDs were washed five
times using a 50kDa cutoff dialysis filter to remove excess free ligands. The QDs in PBS solution
were purified using a 0.2 gm syringe filter and stored at 4 'C for further use.
Conjugation with DNA Oligo and Hybridization with Alexa647-oligo
DBCO-oligo was synthesized by reacting DBCO-PEG 4-NHS ester with a single strand DNA
oligo (5'-/5AmMC6/ACA CCC TTG CAC GTC GTG GAC CTC CTG CGC TA-3'), followed by
purification using a NAP-5 column. About 0.1 nmol of QD-N 3 and 5 nmol of DBCO-oligo were
mixed in 1 mL of PBS and stirred at room temperature for 4 h. The reaction solution was purified
by GFC, and the QD-oligo solution was collected.
The above QD-oligo solution was mixed with 0.1 nmol Alexa647-oligo (5'-/5Alex647N/TAG
CGC AGG AGG TCC ACG ACG TGC AAG GGT GT-3') in 300 pL of PBS. The resulting
solution was stirred at room temperature overnight, followed by analysis using GFC. The fractions
collected by GFC were read on a plate reader for PL signals of QD (Exitation: 450 nm, Detection:
600 nm) and Alexa 647 (Exitation: 630 nm, Detection: 670 nm), respectively.
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In vitro cell labeling for flow cytometry assay
4T1 breast cancer cells were seeded into a 24-well plate at a cell density of 1 x 104 per well and
allowed to attach for 12 h. ManDBCO (50 pM) was added and the cells were incubated at 37 'C
for 72 h. After washing with PBS, cells were incubated with QD-N 3 (1 mg/mL, 10 pL) or QD-
OMe (1 mg/mL, 10 pL) for 2 h and 4 h, respectively. Cells were collected with a cell scraper and
analyzed by flow cytometry.
In vitro cell labeling for confocal imaging
4T1 Cells were seeded onto coverslips in a 6-well plate at a density of 4x 104 cells per well and
allowed to attach for 12 h. ManDBCO (50 pM) was added and the cells were incubated at 37 'C
for 72 h. After washing with PBS, cells were incubated with QD-N 3 (1 mg/mL, 10 pL) or QD-
OMe (1 mg/mL, 10 pL) for 2 h and 4 h. Cells were fixed with 4% paraformaldehyde (PFA) solution,
followed by staining of cell nuclei and membrane with DAPI (2 pg/mL) and CellMask membrane
stain (1 pg/mL), respectively. The coverslips were mounted onto microscope slides and imaged
under a confocal laser scanning microscope.
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Figure 3-8. Confocal images of 4T1 cells treated (upper row) and not treated (lower row) with 50 pM ManDBCO
after incubation with QD-N 3 (50%) for 2h (blue: DAPI; green: Alexa Fluoro 488 membrane stain; red: QD, scale
bar: 10 pm).
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Figure 3-9. Confocal images of 4T1 cells treated (upper row) and not treated (lower row) with 50 tM
ManDBCO after incubation with QD-N 3 (50%) for 4h (blue: DAPI; green: Alexa Fluoro 488 membrane stain;
red: QD, scale bar: 10 pm).
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Figure 3-10. Confocal images of 4T1 cells treated with 50 [tM ManDBCO after incubation with QD-OMe
for 2h (blue: DAPI; green: Alexa Fluoro 488 membrane stain; red: QD, scale bar: 10 [im).
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Figure 3-11. Confocal images of 4T1 cells treated (upper row) and not treated (lower row) with 50 pLM
ManDBCO after incubation with QD-N 3 (100%) for 2h (blue: DAPI; green: Alexa Fluoro 488
membrane stain; red: QD, scale bar: 10 pm).
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Figure 3-12. Representative flow cytometry profiles of 4T1 cells after incubation with QD-
N3 or QD-OMe. The PE-Texas Red channel was used. Cell treatment condition and incubation
time information is provided at the top of each figure.
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Chapter 4
In Vivo Fluorescence Imaging in the Short-wave
Infrared
4.1 Overview of the Following Sections
AuNC
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a)0
E
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Figure 4-1. Gold Nanoclusters that emit beyond 1000 nm are used for shortwave
infrared in vivo imaging.
In the previous three chapters, we described using water-soluble QDs for visible in vitro imaging,
and in the next three chapters we will talk about short-wave infrared (SWIR, 1.0-2.0 ptm) in vivo
imaging. In vivo fluorescence imaging in the SWIR region has drawn increasing attention recently
as the unique optical properties of the tissue in this region enable improved contrast and spatial
resolution over visible and NIR imaging for deep tissue imaging.' 5 This technology has been
shown to be a useful tool for non-invasive in vivo imaging as InGaAs-based SWIR detectors are
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becoming more inexpensive, more portable, and more widely available.6-7 However, wide-spread
use and clinical applications of this technique continuous to be limited by the poor availability of
SWIR emitters with high quantum efficiency, low toxicity, and sufficient physiological stability.9-
10
Metal nanoclusters, especially gold nanoclusters (Au NCs), have been shown to have tunable
emission similar to that of semiconductor QDs. 12-14 The use of visible and near infrared (NIR, 0.7-
1.0 pm) -emitting gold nanoclusters (Au NCs), previously proposed for in vivo imaging, has been
limited to some extent by low quantum yields (QYs) and the limited penetration of visible light in
tissues. 15-17 Since Au has been demonstrated to be biocompatible and potentially nontoxic, we aim
to tune the emission of Au NCs to the SWIR region and use them as fluorescent probes for in vivo
imaging. Here we report SWIR-emitting Au NCs with a relatively high photoluminescence QY
for this wavelength range (0.6% to 3.8% for kem = 1000 to 900 nm) and excellent stability under
physiological conditions. We show that surface ligand chemistry is critical to achieving these
properties. We demonstrate the potential of these SWIR-emitting Au NCs for in vivo imaging in
mice. The Au NCs have a hydrodynamic diameter that is small (-5 nm) enough that they exhibit
a rapid renal clearance, and images taken in the SWIR region show better resolution of the blood
vessels than in the NIR region (Figure 4-1).
4.2 Imaging in the SWIR
Deep tissue imaging has been realized using ionizing radiation, such as X-ray and gamma ray
imaging. However, these procedures pose a potential risk to biological tissues, and thus
fluorescence imaging with lower energy photons is highly preferred. The quality of in vivo
fluorescence imaging has been largely limited by contrast, which is a function of tissue scattering
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and absorption. For Rayleigh scattering, where the scattering particles are much smaller than the
wavelength of incoming light, the scattering intensity is inversely proportional to the fourth power
of the wavelength, thus tissue scattering can be largely reduced at longer wavelengths. In most
tissues, absorbance is dominated by water, melanin, and hemoglobin (Hb), each of which has local
minima and maxima of transmission.8 Therefore, a careful selection of an appropriate imaging
wavelength region that takes both parameters into consideration is of critical importance in order
to realize deep tissue imaging.
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Figure 4-2. (a) Light absorption spectra of hemoglobin and water (part of
the Figure is adapted from ref.1 8). (b) The relative number of transmitted
photons as a function of wavelength at tissue thicknesses of 0.25 cm (solid
line) or 1 cm (dashed line). Figure is adapted from ref.8.
According to previous studies of photon transmittance of tissue samples, 0.7-1.7 pim is the optical
wavelength band for in vivo imaging as photons in this range has the highest penetration rate
through the tissues, mainly due to the strong Hb absorbance at <700 nm and lipid/water absorbance
beyond 1.7 pm (Figure 4-2a).18- 20 Since the absorption spectra of both Hb and water show a
minimum in the traditional NIR region, this window has been explored the most for in vivo
imaging.2 1-22 Despite the big progress of NIR technology, deep tissue imaging remains challenging
as a result of tissue scattering in the NIR region. Current applications are still limited to primarily
small preclinical models (mice, small rates) or to optically accessible tissues (i.e. esophagus, colon)
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in humans."-" Since tissue scattering is further reduced in the SWIR, researchers are investigating
this region for applications that require greater penetration depths.
Although SWIR light is not visible to the eye, the light interacts with objects in a similar manner
to visible light. That is, SWIR light is reflective and can create shadows and contrast in its
imagery.2 5 SWIR technology has found applications in astronomy and military defense, where
sensitive SWIR sensors made of mercury cadmium telluride (HgCdTe) or indium antimonide
(InSb) are utilized. However, these sensors have to work at extremely low temperatures to reach a
high signal-to-noise ratio, requiring a large cooling system installed, which is not suitable for
clinical applications. The development of highly sensitive indium gallium arsenide (InGaAs)
sensors has promoted the use of this technology in fluorescent biomedical imaging research. With
the price decreasing from above $120K to less than $35K and the exempt of some SWIR cameras
from the International Traffic in Arms Regulations, this setup is becoming more available to most
research institutes.
Several recent studies have shown that better contrast and resolution images with better contrast
and resolution of in vivo images can be obtained using SWIR technology compared to traditional
NIR imaging. For example, the Dai group reported using single-walled carbon nanotube (SWNT)-
IRDye-800 conjugates for in vivo imaging in both the NIR region with a silicon camera and the
SWIR region with an InGaAs camera; 2 the Bawendi group has likewise used indocyanine green
as the contrast agent to image a mouse brain vasculature." As shown in Figure 4-3, the image
obtained by the SWIR camera has significantly increased contrast and better resolved details of
the blood vessels of the mouse vasculature. We anticipate that in vivo imaging in the SWIR will
be the trend of in vivo fluorescence imaging research, and that this technology is promising for
future clinical applications.
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Figure 4-3. (a) Microscopy of brain vasculature of a mouse through a cranial window with
NIR detection has poor contrast. (b) The intensity across a line of interest shows insufficient
contrast to resolve overlapping vessels from background signal. (c) Using 1300 nm long-
pass SWIR detection greatly improves image contrast and (d) resolution of vessels. Figures
are adapted from ref.' 1.
4.3 Contrast Agents for SWIR In Vivo Imaging
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While the InGaAs camera is becoming available, further steps toward the development of SWIR
in vivo imaging will require more efficient contrast agents. There have been few reports about
SWIR emitters that can satisfy high quantum efficiency, excellent water solubility, non-toxicity,
and good physiological stability at the same time. Commonly used SWIR emitters include organic
dyes, single-walled carbon nanotubes (SWNTs), Ag2Se QDs, PbS QDs, InAs QDs, and rare earth
doped nanoparticles (Figure 4-4). Most of the SWIR-emitting organic dyes like IR-26 are highly
hydrophobic and suffer from extremely low quantum yield (QY) once being transferred into
aqueous solvents. 9- 0 SWNTs, similarly, exhibit low quantum efficiency and poor stability.26 While
QDs have higher QY and better photostability, the potential toxicity excludes them as candidates
for clinical SWIR in vivo imaging. Hence, developing a potentially nontoxic SWIR contrast agent
with good QY and excellent physiological stability remains challenging.
4.4 Luminescent Gold Nanoclusters
Luminescent noble metal nanoclusters, especially Au NCs with potentially low toxicity,
ultrasmall size, excellent photostability, and facile surface functionalization, are being actively
pursued as novel species of fluorescent materials.13, 2 7 Composed of several to up to a few hundred
Au atoms, these Au NCs exhibit quantum confinement effects and molecule-like properties.13, 28-
30 Au NCs with tunable emission from the ultraviolet to the NIR region have been reported in the
last several decades, and utilization of those Au NCs for in vitro cell labeling and in vivo
fluorescence imaging applications is an active research area. 14-15, 31-32 In earlier reports, Au NCs
with emission in the NIR region are being particularly investigated for in vivo imaging applications
owing to the enhanced tissue penetration enabled by NIR light.15-1 7 As in vivo imaging in the SWIR
range has further reduced background noise from tissue scattering than traditional visible and NIR
imaging, we focus our effort on obtaining Au NCs for SWIR in vivo imaging in this work.
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Recently, substantial progress has been made to improve the photoluminescence (PL) QY of Au
NCs,33 to characterize and establish their atomically precise structures, 34-36 and to understand the
mechanism of their luminescence. 37 However, most of the luminescent Au NCs reported so far
have emission <950 nmi 5 38 and relatively low PL QYs,3 9 limiting their in vivo applications.
Although the luminescence mechanism of Au NCs is still debated and has not yet been well
understood, it is clear that the type and stacking structure of surface ligands play a critical role in
the PL properties of Au NCs.37' 40 Emission of Au NCs in the 800-950 nm range has been achieved
by using a variety of ligands. 41-45 Zwitterionic and bidentate thiol molecules in particular, have
been explored as surface ligands and were shown to result in a higher QY and longer wavelength
emission.46-4 7 We hypothesized that these zwitterionic and bidentate thiol ligands may enable
expansion of the emission spectrum of Au NCs to the SWIR range, thus our work would focus on
tuning the emission spectrum of Au NCs to beyond 1000 nm using a lipoic acid based zwitterionic
ligand.
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Chapter 5
SWIR-emitting Gold Nanoclusters
5.1 Synthesis of SWIR-emitting Au NCs
Au NCs are generally synthesized by reducing chloroauric acid with a reducing agent or by
heating in the presence of thiol ligands such as glutathione, dihydrolipoic acid, or proteins like
bovine serum albumin.1 3 In this study, we first synthesized lipoic acid-based sulfobetaine (LA-
sulfobetaine) -capped SWIR-emitting Au NCs in water by modifying a literature method that
reduces chloroauric acid in the presence of LA-sulfobetaine. 4 These LA-sulfobetaine capped Au
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Figure 5-1. (a) Absorption and photoluminescence spectra and (b) MALDI spectrum of LA-
sulfobetaine capped Au NCs (LA-sulfobetaine:Au=1:1, QY=0.6%), inset is a zoomed-in area
indicated in the blue region on the spectrum. (c) Photoluminescence spectra and (d) Gel filtration
chromatography (GFC) traces of Au NCs (1:1, 1:5, and 1:40, QY=0.6%, 6.2%, and 14.9%,
respectively). PL spectra were acquired using 532 nm excitation.
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NCs have an average inorganic core size of 1.6 nm. Their emission peak is centered at ~1,000 nm
(Figure 5-la), with an initial QY of 0.6%. Matrix-assisted laser desorption/ionization (MALDI)
analysis shows a mass interval of 197 (Figure 5-Ib, Inset), which matches the mass of Au, and the
range of Au atoms in the Au NCs is estimated to be 20-50 by setting the number of Au atoms and
ligands as integers for each m/z value. Au NCs with higher initial QYs can be synthesized by
decreasing the chloroauric acid to LA-sulfobetaine ratio, presumably due to tuning of the core
sizes and the existence of extended ligand layers. As the weight ratio of chloroauric acid hydrate
to LA-sulfobetaine decreases from 1:1 to 1:5, and then to 1:40, the QY increases from 0.6% to
6.2% and 14.9%, respectively. However, the emission peak also blue-shifts (~200 nm) out of the
SWIR range (Figure 5-1c), likely due to different core sizes and surface Au-thiolate staple motifs
created in the presence of the additional ligands during synthesis. 5 This blue-shift of the emission
counterbalances the QY improvement for potential SWIR imaging applications. As we see from
the images of the three Au NCs samples (same Au molar concentration) taken using an InGaAs
camera with two 1,000 nm long pass (LP) filters, the detected signal intensity of the higher QY,
blue shifted Au NCs (1:40) is significantly weaker than that of lower QY but red shifted Au NCs
(1:1 and 1:5) (Figure 5-2).
1:40 1:5 1:1
Figure 5-2. Images of Au NCs (1:40, 1:5, and 1:1, same concentration on Au basis)
in Eppendorf tubes taken with an InGaAs camera and 808 nm excitation.
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Concurrent with the increased QY and the blue-shift in emission, the hydrodynamic diameter
(HD) also slightly increases with more ligands present during synthesis (Figure 5-1d) (4.5 nm, 5.0
nm and 5.2 nm, respectively according to the GFC calibration curve Figure 5-3). The inorganic
Superose 6 column
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Figure 5-3. A Superose 6 size-exclusion column was calibrated with protein standards
containing y-globulin, ovalbumin, myoglobin, and vitamin B12 from Bio-Rad (black
squares). The red curve is a calibration curve based on the protein standards. Our Au NCs
(1:5) had a retention time of about 35 min (arrow), which corresponds to a HD of 5 nm.
a b c
Figure 5-4. TEM images of (a) Au NCs (1:1), (b) Au NCs (1:5), and (c) Au NCs
(1:40). Scale bar represents 5 nm.
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core diameters of these samples are 1.6 nm (1:1), 1.5 nm (1:5), and 1.3 nm (1:40), respectively
(Figure 5-4), indicating the presence of an extended ligand shell that gives rise to the increased
HD. We speculate that an extra layer of LA-sulfobetaine ligands may be bound to the surface of
Au NCs (1:5) and Au NCs (1:40) through electrostatic interactions between ligands or formation
of disulfide bonds between LA-sulfobetaine ligands and exposed thiols on the surface of Au NCs.
Consistent with this hypothesis, MALDI spectra of Au NCs (1:5) and Au NCs (1:40) (Figure 5-5)
show an increased fragmentation, indicating more capping ligands. We hypothesize that a two-
step stacking of LA-sulfobetaine ligands on Au NCs (1:1) would help increase the amount of
surface capping ligand, and that will further lead to increase of QY and perhaps the signal intensity
in the SWIR region.
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Figure 5-5. MALDI spectra of Au NCs (1:5) and Au NCs (1:40).
5.2 Post Ligand Treatment to Increase the QY of Au NCs
To elucidate whether an extended ligand shell contributes to the increased QY and the blue-
shifted emission of Au NCs (1:5 or 1:40), we incubated the low QY Au NCs (1:1) with extra LA-
sulfobetaine ligands. Indeed, following treatment with additional LA-sulfobetaine ligands, the QY
of Au NCs (1:1) significantly increases from 0.6% to 3.8%, accompanied by a ~100 nm blue-shift
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Scheme 5-1. Schematic illustration of zwitterionic ligands capped Au NCs, treated with extra
zwitterionic ligands, resulting in an expanded ligand shell.
(to 900 nm) (Figure 5-6b). Since it is unlikely that the disulfide bond of LA-sulfobetaine can
change the core size of the initial Au NCs (1:1),6-7 which is also verified by inductively coupled
plasma optical emission spectrometry (ICP-OES) result that 96% of the Au was conserved after
additional ligand treatment, we hypothesized the formation of an extended ligand shell (verified
by an increase of 0.5 nm in HD shown by GFC, Figure 5-6c), likely through electrostatic forces
between ligands, and that this led to increased QYs and slight blue-shifts in emissions.
Thermogravimetric analysis (TGA) demonstrates the extended ligand shell of Au NCs after
treatment with additional LA-sulfobetaine ligands (Figure 5-7). All samples were purified using a
desalting column to remove extra free ligands and salts prior to TGA. As shown in Figure 5-7, Au
NCs (1:1) lose ~40% of their original weight when heated to 500 *C, while Au NCs treated with
extra ligands lose -75% of their original weight. We further quantified the amount of ligands
bound to Au NCs via liquid chromatography-mass spectrometry (LC-MS) and inductively coupled
plasma optical emission spectrometry (ICP-OES) (working function is provided in experimental
details). Au NCs were dissolved with potassium cyanide prior to LC-MS and ICP-OES
measurements to quantify the concentration of LA-sulfobetaine and Au, respectively. The results
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Figure 5-6. (a) Images of Au NCs (5:1, 1:1, and 1:5) (0.25 mg/mL on Au basis) in Eppendorf
tubes before (upper row) and after (bottom row) treated with extra LA-sulfobetaine ligands,
taken using InGaAs SWIR camera under 808 nm excitation. (b) PL spectra of Au NCs (1:1
and 1:5) before and after treated with LA-sulfobetaine ligands at 532 nm excitation
(normalized based on the QYs). (c) GFC traces of Au NCs (1:1) before and after treated with
extra LA-sulfobetaine ligands.
show that there is 0.866 mg ligand / mg of Au in nontreated Au NCs, whereas for ligand treated
Au NCs this value was found to be 3.949 (Table 5-1). Since the Au NCs (1:5) initially have a
signal intensity in the SWIR range that is similar to Au NCs (1:1) (Figure 5-2), we treated both
samples with extra ligands for comparison. Images of treated and untreated Au NCs (5:1, 1:1 and
1:5) taken using an InGaAs camera with two 1,000 nm LP filters show that Au NCs (1:1) treated
107
with extra LA-sulfobetaine ligands are the brightest (Figure 5-6a). There is also a slight increase
of the SWIR signal intensity of Au NCs (1:5) after treatment, which is due to an increase in the
QY. However, the blue-shift of the emission results in less signal beyond 1,000 nm (Figure 5-6b).
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Figure 5-7. TGA curves of (a) Au
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Table 5-1. Quantitative analysis of ligand to gold ratio of Au NCs. Au NCs were dissolved using
potassium cyanide, followed by LC-MS analysis. The concentration of LA-sulfobetaine was
calculated using the standard curve in Figure 5-10, and [Au] was measured using ICP-OES.
Au NCs Volume Integrated [LA-sulfobetaine] [Au] LA-sulfobetaine/Au
(mL) Area (mg/mL) (mg/mL) (mg/mg)
Nontreated 0.51 477.7 0.40762 0.47225 0.86631
Treated 0.66 1328.57 1.39597 0.35350 3.94899
Although previous work has revealed some insights into the origin of the luminescence from Au
NCs, the underlying mechanism has not yet been well understood. 8-0 Size (or number of gold
atoms), the structure of the nanocluster cores, the packing of gold-thiolate motifs, and the types of
ligands all play an important role. 8' 11-14 In our case, the extended ligand shell contributes to the
blue-shifted luminescence and higher QY, which is probably due to rigidification of the gold shell
structure that consists several Au-S motifs.15-1 6 To maximize the SWIR signal from Au NCs, we
need to balance a higher QY but a shorter emission maximum with a lower QY but a longer
emission maximum. Au NCs (1:1) treated with extra ligands (Figure 5-6a) provide the highest
brightness in the SWIR, and we use these to demonstrate in vivo SWIR imaging. This preparation
has a relatively good QY (3.8%) and an emission maximum at 900 nm.
5.3 Stability Tests of SWIR-emitting Au NCs
SWIR in vivo imaging can be advantageous as it can allow for deeper penetration and higher
contrast and resolution compared to traditional NIR imaging. Longer-wavelength photons in the
SWIR region experience less scattering in biological tissues. Combined with lower auto-
fluorescence, this enables increased sensitivity and contrast.17 With their small HD, high stability,
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Figure 5-8. Relative photoluminescence intensity and hydrodynamic diameter of Au NCs
at (a) different pH values (4-10) and (b) different ionic strength. (c) 4T1 cell viability after
treatment with Au NCs at different concentrations for 3 days. (d) GFC traces of FBS, Au
NCs (1:1) treated with LA-sulfobetaine ligands, and Au NCs (1:1) treated with LA-
sulfobetaine ligands in FBS, respectively. Absorption was detected at 750 nm.
SWIR emission, and comparatively high QYs, these Au NCs are promising probes for in vivo
imaging. Before applying these NCs to in vivo imaging, we performed a pH and ionic strength
stability test. Au NCs were dispersed in aqueous solutions of different pH values and sodium
chloride solutions of different ionic strengths (0-500 mM), respectively. Both the PL intensity and
HD of the Au NCs demonstrated high stability within physiological pH range and over a broad
range of ionic strength (Figure 5-8 a-b). Moreover, Au NCs show minimal cell toxicity, as
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evidenced by an in vitro MTT assay (Figure 5-8c). Serum stability tests were also carried out to
investigate the stability of the Au NCs against non-specific binding with serum proteins. Au NCs
(900 nm, 3.8% QY) were incubated with fetal bovine serum (FBS) or PBS at 37 "C for 4 hours,
and images under an InGaAs camera shows negligible difference in PL intensity (Figure 5-9). In
addition, the retention time of Au NCs before and after incubation with FBS shows no significant
changes (Figure 5-8c), indicating that the LA-sulfobetaine ligand not only prevents Au NCs from
degradation but also minimizes adsorption of serum proteins in biologically relevant environments,
consistent with previously published results.' 8-20
Figure 5-9. Images of Au NCs in Eppendorf tubes after
incubating with FBS for 4 h at 37 'C (left) and Au NCs
without incubation (right).
These experiments demonstrate that our SWIR-emitting Au NCs exhibit high SWIR brightness,
a small HD below renal filtration threshold, excellent stability against pH and ionic strength, and
minimal non-specific binding. These Au NCs are ready to be employed as contrast agents for
biological imaging applications.
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5.4 Experimental Details
Materials
Lipoic acid, trimethylamine, methanesulfonyl chloride, organic solvents (acetone nitrile, methanol,
chloroform, etc.), PBS buffer, Fetal bovine serum (FBS), and other reagents were purchased from
Sigma Aldrich (St. Louis, MO, USA) unless otherwise noted. N,N-dimethyl-1,3-propanediamine,
1,3-propanesultone, and hydrogen tetrachloroaurate (III) hydrate, 99.9% (metals basis) were
purchased from Alfa Aesar (Haverhill, MA, USA). All chemicals were used as received.
Instrumentation
Transmission electron microscopy (TEM) images of LA-sulfobetaine Au NCs were taken on a
JEOL 2010 advanced high performance TEM. Absorption spectra were taken using a Cary 5000
UV-Vis-NIR spectrophotometer. Photoluminescence measurements were conducted at room
temperature using an Edinburgh FS5 fluorometer with NIR extension. Matrix-assisted laser
desorption/ionization (MALDI) spectra were taken on a Bruker Daltonics UltrafleXtreme MALDI
TOF/TOF using a-cyano-4-hydroxycinnamic acid as the matrix in positive mode.
Thermogravimetric analysis (TGA) was performed using a Discovery TGA thermogravimetric
analyzer. All samples were equilibrated at 100 'C for one hour before increasing the temperature
to remove water. Experiments were conducted under nitrogen flow. The gel filtration
chromatography (GFC) setup was an AKTAprime Plus system equipped with a Superose 6 10/300
GL column. The mobile phase was 1x PBS, and measurements were carried out at a flow rate of
0.5 mL/min. 250 pL of each sample were injected, and absorbance at 280 nm was recorded. Liquid
chromatography-mass spectrometry (LC-MS) analyses were conducted on the Agilent 1290
Infinity LC System equipped with an Agilent 6140 Quadruple mass spectrometer, using
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acetonitrile and water containing 0.1% formic acid as the mobile phases at a rate of 0.6 mL/min.
Gold concentrations for the Au NCs dissolved by potassium cyanide were measured using an
Agilent 5100 ICP-OES. Quantum yields were measured using an integration sphere (Labsphere
RTC-060-SF) under 785 nm diode laser excitation. An 850 nm longpass filter was used to block
the excitation, and signal from the sample was collected using a calibrated germanium detector
(Newport: 818-IR) through a lock-in amplifying system. The measured quantum yields were then
corrected to account for leakage of the excitation light and the transmittance of the filter. SWIR
images were taken using an InGaAs-based SWIR camera (900-1,600 nm) (Nirvana, Princeton
Instruments) under 808 nm excitation and two 1000 nm longpass filters.
Synthesis of lipoic acid based sulfobetaine (LA-sulfobetaine)
LA-amide was synthesized according to a previously reported protocol2' except that the solvent
was changed to acetone nitrile and the buffer used for extraction was changed to 1 M sodium
bicarbonate aqueous solution. Next, 1.5 g of LA-amide was dissolved in 50 mL of methanol and
stirred for 10 min, followed by the successive addition of ammonium hydroxide (0.362 mL, 28%
aqueous solution) and 1,3-propanesultone (0.510 mL). The reaction mixture was stirred at room
temperature for 4 days before it was completely rotary-evaporated, resulting an oily crude product.
Ethanol (50 mL) and hexanes (50 mL) were then added and the mixture was allowed to stand
overnight. LA-sulfobetaine as the precipitate was collected and dissolved in 3 mL of water for
storage.
Synthesis of SWIR-emitting Au NCs
SWIR Au NCs were synthesized by modifying a literature method.4 For Au NCs (1:1), briefly, 1
mg of LA-sulfobetaine was dissolved in 5 mL of DI water. Upon stirring, sodium hydroxide
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aqueous solution (100 ptL, 0.2 M) and hydrogen tetrachloroaurate (III) hydrate (1 mg) in DI water
(50 p.L) were added. The mixture was stirred at room temperature for 5 min, followed by the
dropwise addition of sodium borohydride aqueous solution (100 piL, 50 mM). The mixture was
stirred overnight, and Au NCs were purified via three repeated dialysis steps using a 1 OkDa cutoff
dialysis filter. The Au NCs were dissolved in DI water (400 ptL) and stored at 4 'C. The reaction
yield was about 97%.
Treatment of Au NCs with extra LA-sulfobetaine ligands
10 mg LA-sulfobetaine in 100 pL DI water was added to the stock 400 pL of the Au NC (1:1)
solution under stirring. The reaction was allowed to stand overnight. Au NCs were purified using
a 10K cutoff dialysis filter for 3 times and a NAP-10 column before characterizations. The final
product was dissolved in 0.5 mL aqueous solvent (DI water, Ix PBS or isotonic saline) and stored
at 4 *C. The reaction yield was about 96%.
Quantification of LA-sulfobetaine
A series of LA-sulfobetaine aqueous solution with different concentrations (0.1-10 mg/mL) was
injected into the LC-MS setup. A representative LC spectrum and the corresponding MS spectrum
are shown in Figure 5-10. The areas of the LA-sulfobetaine peak in the LC spectra were calculated.
Thus, a work function of the integrated area versus the concentration of LA-sulfobetaine was
plotted. Au NCs were dissolved using potassium cyanide and analyzed using LC-MS. Based on
the area of the LA-sulfobetaine peak, the concentration can be readily obtained.
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Figure 5410. (a) HPLC trace of LA-sulfobetaine with 254 nm absorption and (b)
Mass spectrum of the largest peak in (a) using LC-MS. (c) Fitting curve of HPLC
integrated area versus concentration of LA-sulfobetaine.
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Serum stability test
150 pL of Au NCs (1:1) treated with LA-sulfobetaine in isotonic saline were mixed with an equal
volume of FBS in an Eppendorf tube. As controls, 150 pL of Au NCs (1:1) treated with LA-
sulfobetaine ligands solution were mixed with 150 pL of isotonic saline, and 150 pL of FBS were
diluted with 150 pL of isotonic saline in separate tubes. The three tubes were placed in a shaker,
warmed to 37 'C, and shaken for 4 h. Each solution was then filtered through a 0.2 pm syringe
filter prior to GFC measurements. An Agilent 1260 Series Bio-inert HPLC system equipped with
an absorbance diode array detector and a Superose 6 column was used for analysis. The mobile
phase was composed of Tris/Tris base (pH 7.5), isotonic NaCl, and 0.02% NaN3. Analysis was
carried out at a flow rate of 0.5 mL/min for all samples: 100 pL of each sample was injected into
the instrument, and absorbance at 280 and 750 nm was recorded.
Cell toxicity test
4T1 breast cancer cells were seeded into a 96-well plate with a cell density of 4k/well and
incubated at 37 C for 12 h for cell attachment. Au NCs with different concentrations (0-50 pg/mL)
were added, and cells were incubated for 3 days. The cell medium was removed, and cells were
washed with PBS twice. MTT reagent (ATCC, 10 pL) was added to each well and the cells were
incubate at 37 'C for 3 h. Purple precipitates were observed. DMSO was then added to dissolve
the purple precipitates for 20 min under shaking. Absorbance at 570 nm was recorded on a plate
reader.
116
.- I A
5.5 Chapter-specific Acknowledgement
I would like to thank Dan Montana, He Wei for the ligand synthesis. I want to thank Hua Wang
for helping with the LC-MS characterization.
References
1. Zhou, C.; Hao, G. Y.; Thomas, P.; Liu, J. B.; Yu, M. X.; Sun, S. S.; Oz, O. K.; Sun, X. K.;
Zheng, J. Near-Infrared Emitting Radioactive Gold Nanoparticles with Molecular
Pharmacokinetics Angew. Chem. Int. Ed. 2012,51, 10118-10122.
2. Shang, L.; Azadfar, N.; Stockmar, F.; Send, W.; Trouillet, V.; Bruns, M.; Gerthsen, D.;
Nienhaus, G. U. One-Pot Synthesis of near-Infrared Fluorescent Gold Clusters for Cellular
Fluorescence Lifetime Imaging Small 2011, 7, 2614-2620.
3. Xie, J. P.; Zheng, Y. G.; Ying, J. Y. Protein-Directed Synthesis of Highly Fluorescent Gold
Nanoclusters J. Am. Chem. Soc. 2009, 131, 888-889.
4. Le Guevel, X.; Tagit, 0.; Rodriguez, C. E.; Trouillet, V.; Leal, M. P.; Hildebrandt, N.
Ligand Effect on the Size, Valence State and Red/near Infrared Photoluminescence of Bidentate
Thiol Gold Nanoclusters Nanoscale 2014, 6, 8091-8099.
5. Jin, R. C. Atomically Precise Metal Nanoclusters: Stable Sizes and Optical Properties
Nanoscale 2015, 7, 1549-1565.
117
6. Lopez-Tobar, E.; Hernandez, B.; Ghomi, M.; Sanchez-Cortes, S. Stability of the Disulfide
Bond in Cystine Adsorbed on Silver and Gold Nanoparticles as Evidenced by Sers Data Journal
of Physical Chemistry C 2013,117, 1531-1537.
7. Nuzzo, R. G.; Allara, D. L. Adsorption of Bifunctional Organic Disulfides on Gold
Surfaces J. Am. Chem. Soc. 1983, 105, 4481-4483.
8. Wu, Z. K.; Jin, R. C. On the Ligand's Role in the Fluorescence of Gold Nanoclusters Nano
Lett. 2010, 10, 2568-2573.
9. Luo, Z. T.; Yuan, X.; Yu, Y.; Zhang, Q. B.; Leong, D. T.; Lee, J. Y.; Xie, J. P. From
Aggregation-Induced Emission of Au(I)-Thiolate Complexes to Ultrabright Au(0)@Au(I)-
Thiolate Core-Shell Nanoclusters J. Am. Chem. Soc. 2012, 134, 16662-16670.
10. Wang, G. L.; Huang, T.; Murray, R. W.; Menard, L.; Nuzzo, R. G. Near-Ir Luminescence
of Monolayer-Protected Metal Clusters J. Am. Chem. Soc. 2005, 127, 812-813.
11. Wang, G. L.; Guo, R.; Kalyuzhny, G.; Choi, J. P.; Murray, R. W. Nir Luminescence
Intensities Increase Linearly with Proportion of Polar Thiolate Ligands in Protecting Monolayers
of Au-38 and Au-140 Quantum Dots J. Phys. Chem. B 2006, 110, 20282-20289.
12. Zeng, C. J.; Liu, C.; Chen, Y. X.; Rosi, N. L.; Jin, R. C. Gold-Thiolate Ring as a Protecting
Motif in the Au-20(Sr)(16) Nanocluster and Implications J. Am. Chem. Soc. 2014, 136, 11922-
11925.
13. Zhang, Z. Y.; Xu, L. J.; Li, H. X.; Kong, J. L. Wavelength-Tunable Luminescent Gold
Nanoparticles Generated by Cooperation Ligand Exchange and Their Potential Application in
Cellular Imaging RSC Adv. 2013, 3, 59-63.
14. Huang, T.; Murray, R. W. Visible Luminescence of Water-Soluble Monolayer- Protected
Gold Clusters J. Phys. Chem. B 2001, 105, 12498-12502.
118
15. Pyo, K.; Thanthirige, V. D.; Kwak, K.; Pandurangan, P.; Ramakrishna, G.; Lee, D.
Ultrabright Luminescence from Gold Nanoclusters: Rigidifying the Au(I)-Thiolate Shell J. Am.
Chem. Soc. 2015, 137, 8244-8250.
16. Deng, H. H.; Shi, X. Q.; Wang, F. F.; Peng, H. P.; Liu, A. L.; Xia, X. H.; Chen, W.
Fabrication of Water-Soluble, Green-Emitting Gold Nanoclusters with a 65% Photoluminescence
Quantum Yield Via Host-Guest Recognition Chem. Mater. 2017, 29, 1362-1369.
17. Hong, G. S.; Zou, Y. P.; Antaris, A. L.; Diao, S.; Wu, D.; Cheng, K.; Zhang, X. D.; Chen,
C. X.; Liu, B.; He, Y. H., et al. Ultrafast Fluorescence Imaging in Vivo with Conjugated Polymer
Fluorophores in the Second near-Infrared Window Nat. Commun. 2014, 5, 4206.
18. Moyano, D. F.; Saha, K.; Prakash, G.; Yan, B.; Kong, H.; Yazdani, M.; Rotello, V. M.
Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity Acs Nano 2014, 8, 6748-
6755.
19. Gupta, A.; Moyano, D. F.; Parnsubsakul, A.; Papadopoulos, A.; Wang, L. S.; Landis, R.
F.; Das, R.; Rotello, V. M. Ultrastable and Biofunctionalizable Gold Nanoparticles Acs Applied
Materials & Interfaces 2016, 8, 14096-1410 1.
20. Oh, E.; Susumu, K.; Goswami, R.; Mattoussi, H. One-Phase Synthesis of Water-Soluble
Gold Nanoparticles with Control over Size and Surface Functionalities Langmuir 2010, 26, 7604-
7613.
21. Zhan, N. Q.; Palui, G.; Grise, H.; Tang, H. L.; Alabugin, I.; Mattoussi, H. Combining
Ligand Design with Photoligation to Provide Compact, Colloidally Stable, and Easy to Conjugate
Quantum Dots Acs Applied Materials & Interfaces 2013, 5, 2861-2869.
119
Chapter 6
SWIR In Vivo Imaging with Gold Nanoclusters
6.1 Rapid Renal Clearance of Au NCs
Efficient renal clearance of functional nanomaterials for contrast is of fundamental importance
for in vivo biomedical applications to ensure that agents can be effectively cleared from the body,
have little accumulation in organs, and show minimum interference with other diagnostic tests. 1-3
To have a general understanding of the biodistribution and renal clearance efficiency of our Au
NCs, Au NCs (0.125 mg Au) treated with extra LA-sulfobetaine were injected into NCRNU-M
mice via the tail vein, and images were taken under 808 nm laser excitation using a SWIR camera
from the front side of the mouse. Signal in the heart, lung and gut of the mice could immediately
a b
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Figure 6-1. A time series of SWIR fluorescence images taken from (a) the
front side and (b) the back side of a mouse after tail vein injection of Au NCs.
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be observed, and renal clearance was observed after 5 min (Figure 6-la). To further demonstrate
that the Au NCs were excreted by the kidneys, a second injection of Au NCs (0.125 mg gold) was
given to the same mouse and images were recorded from the back side. The kidneys are visible
within 1 min and the signal disappears after 18 min (Figure 6-1b). Urine was collected from the
bladder for further analysis. The photoluminescence spectra of the injected Au NCs sample and
the urine overlapped well (Figure 6-2a), indicating that Au NCs were present in the urine. GFC
traces show that the retention time of the Au NCs in the urine is the same as that of Au NCs prior
to injection (Figure 6-2b), indicating negligible size change of the Au NCs before injection and
after being excreted from the mouse. We also took images of the fractions collected by GFC using
our InGaAs camera, which further demonstrates the presence of the Au NCs in the urine and the
consistent HDs before and after injection (Figure 6-3).
b 1.2- - Au NCs before injection
1.00- Au NCs before injection - Experimental mouse urine
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Figure 6-2. (a) Emission spectra and (b) GFC traces of Au NCs before injection into
the mouse (blue curve) and the urine collected from both the experimental mouse
bladder (red curve) and the control mouse bladder (green curve).
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Figure 6-3. Images of GFC fractions of original Au NCs solution (top three rows) and
the urine collected from a mouse that was treated with the Au NCs (bottom three rows),
respectively. Urine fractions were collected starting from 20 min post-injection with
subsequent fractions taken every 0.6 min. Fraction numbers are marked on the wells.
6.2 Biodistribution of Au NCs
The in vivo biodistribution of Au NCs was also investigated by intravenously injecting Au NCs
into FVB mice and subsequently quantifying Au content in different tissues via inductively
coupled plasma mass spectrometry (ICP-MS). As shown in Figure 6-4, Au NCs showed minimal
accumulation in skin, muscle, heart, lungs, brain, and blood at 3 h post injection. Some
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:3 0 -
Figure 6-4. Biodistribution of Au in FVB mice (n=6) at 3 h post injection of Au NCs (0.089
mg of Au). Data were measured using ICP-MS and presented as gg of Au per gram of tissue.
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aFigure 6-5. Ex vivo fluorescence imaging of tissues harvested from mice
treated with Ix PBS (n=3) or Au NCs (n=6) at 3 h post injection (top two
rows: control mouse; lower two rows: experimental mouse; exposure
time: 25 ms).
b
~wit ,>1
Figure 6-6. Images of mouse urine collected at 0.5 h, 1.5 h and 3.0 h post injection
(a) under room light and (b) under SWIR camera (exposure time 2.5 ms, lOx
shorter than in Figure 6-5).
accumulation of Au NCs in mononuclear phagocytic system (MPS) such as liver, spleen, and bone
marrow was observed. Images of the organs taken using an InGaAs camera showed higher signal
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intensities of liver, kidneys, spleen and bone (Figure 6-5), which is consistent with the ICP-MS
result. SWIR imaging of mouse urine collected at 0.5 h, 1.5 h, and 3 h, respectively, showed a
decreased fluorescence intensity over time (Figure 6-6), and ICP-MS analysis indicates Au content
in the urine accounts for about 70% of the injected dose, further demonstrating the rapid clearance
of Au NCs. The clearance of these particles is faster than previously reported Au NCs." 4
6.3 Improved Resolution of SWIR In Vivo Imaging
a b
1,250 nm LP 1,300 nm LP
Figure 6-7. Images of Au NCs (1:1) treated with extra LA-sulfobetaine ligands
taken using an InGaAs camera with (a) 1250 nm LP filter and (b) 1300 nm LP
filter applied.
As seen from the emission spectrum of Au NCs (1:1) treated with extra LA-sulfobetaine ligands,
a long spectral tail exists to beyond 1,300 nm (Figure 5-6b). Despite the lower intensity in this
region, the quality of in vivo SWIR imaging may be better because of the reduced background
signal from tissues. Thus, we took images of this sample using an InGaAs camera with 1,250 nm,
and 1,300 nm LP filters added, respectively. As shown in Figure 6-7, a high SNR was maintained
even after applying a 1,300 nm LP filter. We later injected the sample into a wild type mouse
(C57BL/6), and a set of images of the left leg were taken using a silicon camera with a 850 nm LP
filter and an InGaAs camera with a 1250 nm LP filter respectively under 808 nm excitation. Figure
6-8 shows that a more detailed image of the blood vessels can be discerned from the images taken
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using the InGaAs camera, demonstrating the advantage of SWIR in vivo imaging with Au NCs
over conventional NIR imaging.
b
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Figure 6-8. Images of the left leg of a wild type C57BL/6 mouse taken using (a) a
silicon camera with a 850 nm LP filter, and (b) an InGaAs camera with a 1250 nm LP
filter, respectively (Insets are zoomed-in areas indicated in the red squares). (c-d) The
intensity across a line of interest drawn in the inset images above.
6.4 Summary
In summary, we have developed water-soluble LA-sulfobetaine capped Au NCs with good QYs
that emit in the SWIR. The SWIR emitting Au NCs have small HDs, minimum non-specific
binding and rapid renal clearance. In vivo imaging of these Au NCs shows a higher contrast and
resolution in the SWIR than in the more conventional NIR region, demonstrating the potential of
SWIR imaging to improve in vivo imaging using Au NCs.
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6.5 Experimental Details
Instrumentation
The gel filtration chromatography (GFC) setup was an AKTAprime Plus system equipped with a
Superose 6 10/300 GL column. The mobile phase was Ix PBS, and measurements were carried
out at a flow rate of 0.5 mL/min. 250 piL of each sample was injected, and absorbance at 280 nm
was recorded. Mouse tissues and blood were digested using aqua regia using a Milestone
UltraWave microwave sample digestion system, and the gold content in each tissue or blood
sample was measured using an Agilent 7900 ICP-MS. In vivo imaging data were recorded using
an InGaAs-based SWIR camera (900-1,600 nm) (Nirvana, Princeton Instruments) and a silicon
based camera (PIXIS, Princeton Instruments) under 808 nm excitation and different longpass
filters (Thorlabs and Edmund Optics) as indicated.
Animals
Eight-week-old NCRNU-M mice were purchased from Taconic (Hudson, NY). Fifteen-week-old
FVB mice were purchased from Charles River Laboratories. A C57BL/6 mouse (male, 8 weeks)
was purchased from The Jackson Laboratory. The animal protocol was reviewed and approved by
the Institutional Animal Care and Use Committee at the Massachusetts Institute of Technology.
In Vivo SWIR Imaging
NCRNU-M mice were anesthetized by intraperitoneal injection of ketamine (200 [tL) and xylazine
(100 VtL) in isotonic saline (700 iL) (150 ptL/30g mouse). A tail vein catheter was inserted after
mice were unresponsive to toe pinch. Mice were placed on the imaging stage to collect background
images for the assessment of animal autofluorescence. Mice were then intravenously injected with
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Au NCs (1:1) treated with LA-sulfobetaine ligands (200 pL/mouse, 0.125 mg of Au) to observe
the injection and initial distribution of Au NCs in the blood. First dose of Au NCs (0.125 mg of
Au) was injected, and video was taken from the front side. About 20 min later, a second dose of
Au NCs (0.125 mg of Au) was injected via the tail vein, and video was taken from the back side
of the mice.
A C57BL/6 mouse was anesthetized using the same method as mentioned above, and the hair on
the left leg was shaved. Au NCs (0.5 mg of Au) was injected via tail vein, and images of the left
leg were taken using a silicon camera with an 850 nm longpass filter applied. Another dose of Au
NCs (0.5 mg Au) was injected via the tail vein, and images of the left leg were taken using an
InGaAs camera equipped with 1,000 nm, 1,150 nm, and 1,250 nm longpass filters, respectively.
Biodistribution
200 iL of Au NCs (0.089 mg of Au determined by ICP-MS) was injected via tail vein into six
FVB mice each. Three control FVB mice were injected with 200 uLix PBS each. Mouse urine
was collected at 0.5 h, 1.5 h and 3.0 h post injection, respectively. Organs and blood were harvested
from both the experiment and control group of mice at 3 h post injection and stored in pre-weighed
petri dishes and Eppendorf tubes. The petri dishes and Eppendorf tubes were weighed again to get
the weight of each organ or blood sample. The samples were then digested using aqua regia by the
microwave digester. The resulting clear solutions were diluted for ICP-MS analysis.
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